Giuseppe
Mandraffino
Email: 
giuseppe.mandraffino@unime.it
Allegati: 

ALTRE INFORMAZIONI

SSD: MED/09
Profilo: Professori Associati

CURRICULUM

Curriculum

     
Curriculum Vitae    
     
Personal information    
First name(s) / Surname(s)  Giuseppe Mandraffino  
Work Address(es) Dipartimento di Medicina Clinica e Sperimentale
V. Consolare Valeria Gazzi, University Hospital G. Martino
 
Telephone(s) +39 0902212359 Mobile:    
Fax(es) +390902212372  
E-mail gmandraffino@unime.it or gmandraffinomd@libero.it  
PEC g.mandraffino-8901@pec.omceo.me.it  
Nationality Italian  
Date of birth May 11, 1980  
Gender Male  
     
Posizione accademica     
  RTD L240/10 Tipo B SSD 06/B1  
  Abilitato alle funzioni di Professore Associato 06/B1 (Medicina Interna) 
Giusta procedura abilitativa nazionale ASN - BANDO D.D. 1532/2016 SETTORE CONCORSUALE 06/B1 MEDICINA INTERNA (pubblicazione 19.10.2018)
 
Incarichi di Docenza
 
·       Docente nell’Università degli Studi di Messina con gli incarichi:   
·        CdL Medicina e Chirurgia
CI Medicina Interna 
CI Emergenze Medico-Chirurgiche 
CI Semeiotica e Metodologica Clinica
 
·       Scuola di Specializzazione in Medicina Interna 
·       Scuola di Specializzazione in Geriatria
·       Scuola di Specializzazione in Cardiologia
·       Scuola di Specializzazione in Chirurgia Toracica 
·       Scuola di Specializzazione in Radiodiagnostica
·       Scuola di Specializzazione in Ematologia
·       Scuola di Specializzazione in Neurologia
·       Scuola di Specializzazione in Farmacologia e Tossicologia Clinica Area Medica
·       Scuola di Specializzazione in Farmacologia e Tossicologia Clinica Area non medica 
 
·       Scuola di Dottorato di Ricerca in Scienze Biomediche Sperimentali e Cliniche (XXXII-XXXIII-XXXIV ciclo)
·       International PhD Course in Clinical and Experimental Medical Science 
 
Scuola di Formazione Specifica in Medicina Generale - Triennio 2018/2021 - Polo di Messina
     
Incarichi precedenti
(AA 2014-2019)
·       AA 2016-17 e 2017-18: Reumatologia – CdL Medicina e Chirurgia
  • AA 2016-17 e 2017-18: Reumatologia – CdL Scienze Infermieristiche
  • AA 2017-18: Reumatologia – CdL Fisioterapia
 
     
Relatore Tesi   Relatore di 30 Tesi di Laurea per il CdL in Medicina e Chirurgia
Relatore di 3 Tesi di Specializzazione per la SdS in Medicina Interna
Relatore di 1 Tesi di Laurea per il CdL in Scienze Infermieristiche
 
Academic tasks
(since 26.02.2018)
International Mobility Program, Master Degree in Medicine and Surgery   
     
Posizione Assistenziale Responsabile Centro Lipigen per la Diagnosi e la Cura delle Dislipidemie
UOC di Medicina Interna  
 
     
Formazione    
2009-2012
PhD  
Clinical and Experimental Medicine [XXV ciclo]  
University of Messina
   
   
2004-2009
Internal Medicine Specialist  
University of Messina
   
   
1998-2004
MD, Medical Doctor  
Master Degree in Medicine and Surgery   
University of Messina  
   
     
Personal skills and competences    
Mother tongue(s) Italian  
Other language(s) English, French  
Self-assessment   Understanding Speaking Writing
European level (*)   Listening Reading Spoken interaction Spoken production  
English     C1   C2   C2   C2   C2
French     B1   C1   B1   A2   A1
  (*) Common European Framework of Reference for Languages  
     
Expert Panel APEX (Atherosclerosis Prevention Scientific Exchange), member for “Practical aspects in the management of statin associated muscle symptoms (SAMS)” *
*Laufs U, Filipiak KJ, Gouni-Berthold I, Catapano AL; SAMS expert working
group (Mandraffino G; Benlian P.). Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl. 2017 Apr; 26:45-55. doi: 10.1016/S1567-5688(17)30024-7. PMID: 28434484.
 
     
Advisory Board  - “The clinical relevance of Odissey Outcomes data in real life”; Web Conference, 9 maggio 2019 - SANOFI

 - “L'acido Bempedoico come nuova opzione nel trattamento delle dislipidemie”, 26 Novembre 2020 – DAICHI-SANKYO
 

 - “Q&A con l’HCP”; 15.01.2021 – NOVONORDISK 
 
·         
     
Membro di Società scientifiche SISA/EAS; SIMI; ESH.  
     
Societies board member SISA (sez. “Siculo-Calabra”) (2015-2018, 2018-current)
SISA – “GRUPPO GIOVANI” – National Board (former, 2016-2019) 
SIMI (sez. Sicilia) (2019 – attuale)
 
     
Scientific activities,
 (briefly) 

 
Speaker/Chairman/Faculty at National, Regional and Interregional meetings by National and International Scientific Societies (SISA; SIMI, AMD/SID, SIC, AICPR, SIPMEL, EAS, ESH).
 
Scientific Committee for several scientific meetings: SISA National meetings, SISA Young Investigators meetings, SISA Siculo-Calabro meetings (both local and National coverage) 
 
SIMI Sicily regional meetings
 
Active SISA member since 2004; author/co-author of more than 70 original contributions so far, accepted as oral communication or poster presentation at National meetings (SISA National meeting; Spring Meeting).
 
Speaker/Lecturer in a number of training course for medical specialists and/or general practitioners on cardiovascular risk and dyslipidemia, including CME
 
     
Journal Editorial Board  
     
Peer Reviewing Activity
  • Ageing [ONLINE ISSN: 1945-4589]
  • Atherosclerosis [ISSN:0021-9150 (Print); 1879-1484 (Electronic); 0021-9150 (Linking)]
  • Biomedicine [EISSN 2227-9059, Published by MDPI]
  • Biomolecules [EISSN 2218-273X, Published by MDPI]
  • BMJ Open [ISSN 2044-6055]
  • British Journal of Medicine and Medical Research [ISSN: 2231-0614]
  • Cardiology Research and Practice [ISSN: 2090-8016 (Print); 2090-0597 (Online)]
  • Cardiovascular Diabetology [ISSN: 1475-2840]
  • Cell Transplantation: The Regenerative Medicine Journal [ISSN: 0963-6897; E-ISSN: 1555-3892]
  • Clinical and Experimental Pharmacology and Physiology [ISSN: 1440-1681 - Online] 
  • Disease Markers: [ISSN: 0278-0240 (Print), ISSN: 1875-8630 (Online)]
  • European Heart Journal [ISSN: 0195-668X]
  • European Journal of Preventive Cardiology [ISSN: 2047-4873 - Online ISSN: 2047-4881]
  • Experimental and Therapeutic Medicine [ISSN: 1792-0981 - eISSN: 1792-1015]
  • Frontiers in Cardiovascular Medicine [ISSN: 2297-055X]
  • Hypertension Research [ISSN:0916-9636 -Print; 1348-4214 -Electronic; 0916- 9636 Linking] 
  • International Journal of Cardiology [ISSN: 0167-5273]
  • International Journal of Molecular Medicine [Print ISSN: 1107-3756; Online ISSN: 1791-244X]
  • International Journal of Molecular Science [EISSN 1422-0067, Published by MDPI ]
  • International Journal of Rheumatic Diseases [ISSN: 1756-185X]
  • Journal of Clinical Lipidology [ISSN: 1933-2874] 
  • Journal of Human Hypertension [ISSN: 0950-9240 –Print; 1476-5527 - Electronic;0950-9240 –Linking] 
  • Medical Principles and Practice [ISSN: 1011-7571 (Print) e-ISSN: 1423-0151 (Online)]
  • Medicine [ISSN: 0025-7974 - Online ISSN: 1536-5964]
  • Molecular and Cellular Biochemistry [ISSN: 0300-8177 (print); ISSN: 1573-4919 (electronic)
  • Nicotine and Tobacco Research [ISSN 1462-2203 –Print; 1469-994X – Electronic; 1462-2203 Linking] 
  • Nutrition [ISSN: 0899-9007]
  • Nutrition Metabolism and Cardiovascular Disease [ISSN: 0939-4753]
  • Oncotarget [ISSN: 1949-2553]
  • PLOS one [ISSN: 1932-6203 –Electronic; 1932-6203 Linking] 
  • Rheumatology [Online ISSN 1462-0332 - Print ISSN 1462-0324]
  • Scandinavian Journal of Rheumatology [ISSN 0300-9742 (Print), 1502-7732 (Online)] 
  • Scientifica: [ISSN 2090-908X (Online)] 
  • The Open Rheumatology Journal [ISSN: 1874-3129]
 
     
Current investigations Main research focus: 
Lipids interaction with other cardiovascular risk factors: vascular and cardiac clinical and subclinical damage; mediators, markers, outcomes. 
  • Endocan plasma levels in patients with Cardiovascular risk factors 
  • Endocan plasma levels in patients with Rheumatoid arthritis
  • Endocan plasma levels in patients with Psoriatic arthritis
  • MicroRNA levels in patients with different conditions characterized by high cardiovascular risk
  • MicroRNA before and after pharmacologic treatment
  • CD34+ cells in peripheral blood in patients with different conditions characterized by high cardiovascular risk
  • CD34+ cells in peripheral blood before and after pharmacologic treatment
  • Lp(a) in different clinical conditions (metabolic syndrome, pregnancy, hyperlipidemia) 
  • Lp(a) change during last frontier therapies: antiPCSK9 monoclonal antibodies
  • Treatment with iPCSK9 and change in vascular mechanical properties, CD34+ cell number, vascular damage and signal molecules.
  • Treatment with Sacubitril/valsartan and change in subtle mechanical properties of left ventricle
 
     
                             
 

 
Invited speaker
(Scientific Societies)

 
  1. SIMI: VIII Congresso Regionale Della Societa’ Italiana Di Medicina Interna Sezione Sicilia – Messina–8-9 Novembre 2019
    • Lettura: “Inibitori di PCSK9: è tempo di ripensare al goal terapeutico?”
  2. IV Congresso Congiunto AMD-SID Sicilia 2019 – 24-25 Ottobre 2019
V SESSIONE SID: Nuovi anticoagulanti orali e terapia antiaggregante nel diabete 
  • Lettura: I nuovi anticoagulanti orali
  1. SIC: “Prevenzione e trattamento delle malattie cardiovascolari”
    • Lettura “Ipercolesterolemia, quale ruolo per gli integratori?”. Roma 17-18 settembre 2019
  2. SISA 32° congresso nazionale; Sessione: Nuovi biomarcatori e target di danno ateromasico 
    • Lettura “Cellule progenitrici circolanti e proteoglicani”. Bologna, 25-27/11/2018
  3. SISA-SIIA-SIMI: Relazione su invito Spring Meeting Giovani Ricercatori SIIA, SIMI, SISA - Evento Intersocietario a carattere Nazionale Tavola rotonda "Forthcoming Projects" – Rimini 6-7 Aprile 2018
    • Lettura: “Il Progetto Lipigen”
  4. SIMI: VII Congresso Regionale Della Societa’ Italiana Di Medicina Interna Sezione Sicilia – Cefalù – 1-2 Dicembre 2017
    • Lettura: “Gestione clinica del paziente ad alto rischio”
  5. SISA: Congresso annuale della sezione siculo-calabra della Società Italiana dell’Aterosclerosi – Castel di Tusa, 9 ottobre 2017
    • Lettura: “Cellule progenitrici circolanti e patologia cardiovascolare: cose c’è di nuovo?”
  6. SIC-SIEC: XIV International Meeting of Echocardiography. Hilton Giardini Naxos - October, 6–8, 2016
    • Lettura: “Treatment of arterial hypertension: state of the art”
  7. SIMI: La Medicina Interna: ricerca, evidenze scientifiche e metodologia clinica; Vibo Valentia - April, 19-21, 2007.
    • Lettura: “Le ipolipidemie sono sempre protettive?”
  8. AICPR – Associazione Italiana di Cardiologia Clinica, Preventiva e Riabilitativa, 11 Congresso regionale, 11.05.2019, Messina
    • Lettura: ESC 2017: novità nella gestione del paziente con fibrillazione atriale
  9. SIPMEL – Società Italiana di Patologia medica e Medicina di Laboratorio - sez reg Siciliana – 25 maggio 2018
    • Lettura: Individuazione di marcatori predittivi di efficacia e di sanguinamento
  10. SISA (patr.): “Dislipidemie familiari: un iceberg da scoprire”; I edizione – Messina 12 maggio 2012 
    • Lettura: Dislipidemie familiari e Ipercolesterolemia
    • Lettura: Screening dei pazienti: metodi e strumenti
    • Lettura: Prescrizione: Nota 13 (prima parte)
  11. SISA (patr.): “Dislipidemie familiari, un iceberg da scoprire”; II edizione – Giardini Naxos (ME) 3 novembre 2012 
    • Lettura: Dislipidemie familiari e Ipercolesterolemia
    • Lettura: Screening dei pazienti: metodi e strumenti
    • Lettura: Prescrizione: Nota 13 (prima parte)
  12. SISA (patr.): La prevenzione nel paziente a rischio cardiovascolare: Facciamo tutti il possibile?” Messina - October, 24, 2015
    • Lettura: “Il paziente ad elevato rischio CV: Aspetti pratici”
  13. SISA-SIIA: Spring Meeting Giovani Ricercatori, Rimini - March, 11-12, 2016
    • Lettura: “Change in miRs 145, 221 and 222 expression in hypertensive subjects treated with enalapril, losartan or olmesartan”
  14. ESH26th (European) Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13, 2016 (European Society of Hypertension)
    • Lettura: “Circulating progenitor cells in hypertension: effectiveness of a treatment with olmesartan in improving cell number and miRs profile besides expected pharmacological effects”
Lo slot come Lettura è stato parte del premio conseguito nella sessione poster nel contesto dell’evento (Alberto Ferrari Poster Prize)
  1. SISA (patr.): “Before, Il controllo della dislipidemia nella prevenzione CV” – Messina, 20 maggio 2017 (anche Responsabile scientifico)
    • Lettura“Dislipidemia e Aterosclerosi”
 
Direzione e partecipazione alle attività di un gruppo di ricerca caratterizzato da collaborazioni a livello nazionale o internazionale  
·     Principal investigator locale per lo studio: Treatment of High and Very high riSk dysplipidemic pAtients for the PreveNTion of cardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI) (CE 45-20, November, 11th, 2020)
·     Principal Investigator locale dello studio multicentrico LIPIGEN: (Lipid TransPort Disorders Italian Genetic Network)
 
Società Scientifica di supporto: Società Italiana per lo Studio dell'Arteriosclerosi (SISA); Fondazione SISA
Ruolo Scientifico: Principal Investigator (studio multicentrico)
Ruolo Assistenziale: Responsabile Ambulatorio LIPIGEN Messina - UOC Medicina Interna - AOU Policlinico G. Martino - Università degli Studi di Messina - Comitato Etico Interaziendale. Dalla collaborazione in network nazionale sono finora stati pubblicati 3 lavori:

1: Pirillo A et al; Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study. Atheroscler Suppl. 2017 Oct;29:17-24. doi: 10.1016/j.atherosclerosissup.2017.07.002. PubMed PMID: 28965616.
2: Averna M et al; LIPIGEN Group. Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN). Atheroscler Suppl. 2017 Oct;29:11-16. doi: 10.1016/j.atherosclerosissup.2017.07.001. PubMed PMID: 28965615.
3: Casula M. et al; Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study. Atherosclerosis. 2018 Oct;277:413-418. doi: 10.1016/j.atherosclerosis.2018.08.013.
dal 16-06-2016 a oggi
·     Principal Investigator locale dello studio multicentrico PROSISA: (Project Statin Intolerance SISA)
Società Scientifica di supporto: Società Italiana per lo Studio dell'Arteriosclerosi (SISA); Fondazione SISA
Ruolo Scientifico: Principal Investigator (studio multicentrico)
Ruolo Assistenziale: Responsabile Ambulatorio LIPIGEN Messina - UOC Medicina Interna - AOU Policlinico G. Martino - Università degli Studi di Messina - Comitato Etico Interaziendale prot. n 115/16. I dati ottenuti nel programma sono stati comunicati al Congresso Nazionale della SISA 2019. Dalla collaborazione in network nazionale è stato finora pubblicato 1 lavoro 
1.     M Casula, M Gazzotti, F Bonaiti, E OImastroni, M Arca, M Averna, A Zambon, A L Catapano, PROSISA Study Group Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study. J Intern Med. 2020 Dec 1. doi: 10.1111/joim.13219
dal 08-11-2016 a oggi 
·     Partecipazione ad un Gruppo di Ricerca Nazionale che coinvolge il Dipartimento di Terapia Intensiva Pediatrica dell'Ospedale Bambino Gesù (Roma), il Centro Mediterraneo di Cardiologia Pediatrica dell'Ospedale Bambino Gesù (Taormina), ed il Dipartimento di Medicina Clinica e Sperimentale dell'Università degli Studi di Messina (Cardiologia e Medicina Interna).
Il Gruppo si occupa della gestione degli aspetti cardiovascolari, morfologici ed emodinamici, predittivi di outcome cardiovascolare nell'ambito delle cardiopatie congenite.
 Ad oggi i risultati ottenuti dalla collaborazione sono stati pubblicati in due articoli a stampa su riviste di rilevanza internazionale:

1.     Oreto L, Mandraffino G, et al; Atrial septal defect morphology and stenting in hypoplastic left heart syndrome after hybrid palliation. Cardiol Young. 2018 Feb;28(2):252-260.

2.     Manuri L, ..., Mandraffino G, et al; Early hybrid approach and enteral feeding algorithm could reduce the incidence of necrotising enterocolitis in neonates with ductus-dependent systemic circulation. Cardiol Young. 2017 Jan;27(1):154-160.
 L'attività di ricerca congiunta per il 2017-2019 è volta alla valutazione di indici morfologici, emodinamici e di outcome (prima e dopo correzione chirurgica della cardiopatia congenita) relativi ad una procedura ponte definita "hybrid palliation", ed un secondo filone di ricerca è attivo sulla valutazione comparativa (studio longitudinale di outcome) di due differenti tecniche di ablazione dei focolai aritmogeni (RF vs Crio).
 
Il programma di ricerca 2018-20 è intitolato “Studio ecocardiografico delle pressioni di riempimento e della funzione diastolica in pazienti in età pediatrica affetti da cardiopatia congenita e sottoposti ad intervento cardiochirurgico/ cateterismo cardiaco

dal 01-10-2015 a oggi 
·     Partecipazione ad un Gruppo di Ricerca Nazionale che coinvolge il Centro Nemo (NEuroMuscular Omnicentre) ed il Dipartimento di Medicina Clinica e Sperimentale dell'Università degli Studi di Messina (Cardiologia, Medicina Interna)
L'attività di ricerca del Gruppo è focalizzata sulla valutazione di indici funzionali e predittivi di outcome cardiovascolare in pazienti affetti da Distrofie Muscolari Genetiche (prevalentemente Snd di Duchenne).
I risultati della ricerca sono stati presentati nell'anno 2017 ai Congressi di diverse Società Scientifiche Nazionali ed Internazionali. 
pubblicato ad oggi 1 articolo
1.     Oreto L, Vita GL, Mandraffino G, Carerj S, Calabrò MP, Manganaro R, Cusmà-Piccione M, Todaro MC, Sframeli M, Cinquegrani M, Toscano A, Vita G, Messina S, Zito C., Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance; Acta Myol. 2020 Dec 1;39(4):191-199.  doi: 10.36185/2532-1900-022. 

dal 01-10-2016 a oggi 
·     Membro del <<SAMS Expert Working Group>>, gruppo di lavoro internazionale (Expert Panel Europeo) per la gestione dei sintomi muscolari associati a trattamento statinico.
 Il lavoro del Gruppo ha dato origine ad 1 pubblicazione scientifica (su Atherosclerosis Suppl), in forma di Consensus Paper: 
1.     Laufs U et al. Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl. 2017 Apr; 26:45-55. doi: 10.1016/S1567-5688(17)30024-7. PubMed PMID: 28434484 (2015-2017).
·     Partecipazione al programma di sorveglianza farmacologica FORWARD (Facilitation of reporting in hospital Ward) 
Dati ottenuti dal programma sono stati oggetto di pubblicazione
1.     Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. C Giardina, ..., G Mandraffino, et al. Frontiers in Pharmacology 2018: 9, 350. doi: 10.3389/fphar.2018.00350
FORWARD: Programma per lo sviluppo del Servizio Sanitario Regionale 2010; Sede direzionale Policlinico Universitario di Messina G. Martino; responsabile del progetto: prof. Vincenzo Arcoraci 
dal 01-06-2016 a oggi 
·     Partecipazione ad un Gruppo di Ricerca Nazionale che vede coinvolti: Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Messina (Medicina Interna, Cardiologia), Cardiologia con UTIC dell'Ospedale Pugliese-Ciaccio di Catanzaro; Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Pisa; Dipartimento di Medicina Interna dell'Università di Verona. 
Ad oggi l'attività di ricerca del gruppo ha prodotto 6 pubblicazioni a stampa su riviste di rilevanza internazionale (vedi allegato) 
dal 01-09-2013 a oggi 
·     Referente LIPIGEN per lo studio POSTER (PREVALENCE OF FAMILIAL HYPERCOLESTEROLAEMIA (FH) IN ITALIAN PATIENTS WITH CORONARY ARTERY DISEASE) (studio Promosso congiuntamente da ANMCO e SISA). 
2016-2018 
·     Gruppo Giovani Ricercatori SISA: partecipazione (e rappresentazione in seno al Comitato Coordinatore del Gruppo) ad un gruppo di Ricerca Nazionale.
Main topic: "Novità nello studio dell'Aterosclerosi e sue complicanze"
URL: http://www.sisa.it/index.php?class=Comp& className=Content&op=Show¶m=cid,958, preview,0
. Il Gruppo organizza annualmente un Meeting Nazionale Intersociaterio (hanno collaborato SIMI e SIIA), e ha lo scopo di promuovere Progetti di Ricerca originali intersocietari, coinvolgendo i Giovani Ricercatori delle tre Società Scientifiche Nazionali coinvolte. 
I dati ottenuti nel programma sono stati comunicati al Congresso Nazionale della SISA 2018 e 2019.
dal 22-11-2016 a oggi 
·     Principal Investigator centro 33017 (Messina) studio multicentrico osservazionale <<20130296>>, "Site Evaluation" , prot CE interaziendale n 15/17 
dal 20-02-2017 a oggi 
·     Partecipazione ad un progetto di ricerca internazionale dal titolo “Unravelling the links among lipid metabolism, immune system and vascular damage in chronic conditions: towards novel biomarkers and therapeutic targets” (reference PI19/00081) submitted by Prof. Dr. Ana Suárez Díaz from the University of Oviedo to the Instituto de Salud Carlos III (Acción Estratégica en Salud 2019) progetto condiviso tra il nostro Gruppo di Ricerca nell’Università di Messina - Dipartimento di Medicina Clinica e Sperimentale, il Dott. Javier Rodriguez-Carrìo ed il Prof. Ana Suarez dell’Università di Oviedo.
·     Coordinamento di un progetto di ricerca internazionale dal titolo "New markers of preclinical cardiovascular impairment in chronic inflammatory disease";
 Collaborano al gruppo di ricerca il Dipartimento di Medicina Clinica e Sperimentale dell'Università degli Studi di Messina (Medicina Interna, Laboratorio di Biochimica e Biologia Molecolare), e l'Area of Immunology, Department of Functional Biology, Faculty of Medicine, University of Oviedo, Oviedo, Spain [Coll: Javier Rodriguez-Carrìo, MSc, PhD; Ana Suarez, Profesor asociado]
. Il gruppo di ricerca è impegnato nello studio di indicatori precoci di malattia e di danno cardiovascolare in condizioni di incrementato stress ossidativo associato a stato flogistico di alto, medio e basso grado, attraverso la valutazione delle alterazioni precoci ai costituenti della matrice extracellulare e alle proprietà meccaniche di cuore e vasi; i lavori del gruppo hanno già portato alla pubblicazione di quattro articoli in extenso su riviste internazionali: 
1. Lo Gullo A, Rodríguez-Carrio J, Gallizzi R, Imbalzano E, Squadrito G, Mandraffino G. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients. Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30057-8. doi: 10.1016/j.pcad.2020.03.005. [Epub ahead of print] Review. PubMed PMID: 32201285.
2. Lo Gullo A, Rodríguez-Carrio J, Aragona CO, Dattilo G, Zito C, Suárez A, Loddo S, Atteritano M, Saitta A, Mandraffino G. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation. Atherosclerosis. 2018 Apr;271:214-222. doi: 10.1016/j.atherosclerosis.2018.03.004. Epub 2018 Mar 2. PubMed PMID: 29524864.
3: Mandraffino G, Scicali R, Rodríguez-Carrio J, Savarino F, Mamone F, Scuruchi M, Cinquegrani M, Imbalzano E, Di Pino A, Piro S, Rabuazzo AM, Squadrito G, Purrello F, Saitta A. Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience. J Clin Lipidol. 2020 Feb 4. pii: S1933-2874(20)30015-5. doi: 10.1016/j.jacl.2020.01.015. [Epub ahead of print] PubMed PMID: 32111581.
4: Scuruchi M, Potì F, Rodríguez-Carrio J, Campo GM, Mandraffino G. Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158545. doi: 10.1016/j.bbalip.2019.158545. Epub 2019 Oct 28. Review. PubMed PMID: 31672572. altri dati preliminari sono stati inviati in forma di contributo originale del gruppo di ricerca (abstracts) e accettati a congressi di Società scientifiche nazionale (SISA/SIIA/SIMI, Spring meeting intersocietario 2020) ed internazionali (EAS 2020; EULAR 2020). 

dal 14-08-2017 a oggi 
   
 
Articoli pubblicati 68 (source: Pubmed, Scopus) – May, 20th, 2021.
   
Metriche Impact Factor: >200 (Clarivate Analytics); 
H-index: 19; citations: 1059 (source: Scopus)
   
Publication List
(International peer-reviewed Journals)
1.   Scuruchi, M., D’Ascola, A, Avenoso, A, Mandraffino, G., Campo, S., Campo, G.M., Endocan, a novel inflammatory marker, is upregulated in human chondrocytes stimulated with IL-1 beta. Molecular and Cellular Biochemistry; Volume 476, Issue 3, March 2021, Pages 1589-1597
2.   Lilia Oreto, Gian Luca Vita, Giuseppe Mandraffino, Scipione Carerj, Maria Pia Calabrò, Roberta Manganaro, Maurizio Cusmà-Piccione, Maria Chiara Todaro, Maria Sframeli, Maria Cinquegrani, Antonio Toscano, Giuseppe Vita, Sonia Messina, Concetta Zito. Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance. Acta Myol. 2020 Dec 1;39(4):191-199. doi: 10.36185/2532-1900-022. eCollection 2020 Dec.
3.   Avenoso A, Campo S, Scuruchi M, Mania M, Innao V, D'Ascola A, Mandraffino G, Allegra AG, Musolino C, Allegra A. Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects. Pathol Res Pract. 2020 Dec 13;218:153317. doi: 10.1016/j.prp.2020.153317. Online ahead of print.PMID: 33360970
4.   Casula M, Gazzotti M, Bonaiti F, OImastroni E, Arca M, Averna M, Zambon A, Catapano AL; PROSISA Study Group. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study. J Intern Med. 2020 Dec 1. doi: 10.1111/joim.13219. Online ahead of print. PMID: 33259671
5.   D'Ascola A, Scuruchi M, Ruggeri RM, Avenoso A, Mandraffino G, Vicchio TM, Campo S, Campo GM. Hyaluronan oligosaccharides modulate inflammatory response, NIS and thyreoglobulin expression in human thyrocytes. Arch Biochem Biophys. 2020 Nov 15;694:108598. doi: 10.1016/j.abb.2020.108598. Epub 2020 Sep 22. PMID: 32976824
6.   Avenoso A, D'Ascola A, Scuruchi M, Mandraffino G, Campo S, Campo GM. miR146a up-regulation is involved in small HA oligosaccharides-induced pro-inflammatory response in human chondrocytes. Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129731. doi: 10.1016/j.bbagen.2020.129731. Epub 2020 Sep 12. PMID: 32931869
7.   Mandraffino, G., Scicali, R., Squadrito, G. Author's reply to: Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia, a letter from Papaioannou and colleagues. Journal of Clinical Lipidology, 2020. Volume 14, Issue 4, July - August 2020, Page 543
8.  Mandraffino G, Imbalzano E, Lo Gullo A, Zito C, Morace C, Cinquegrani M, Savarino F, Oreto L, Giuffrida C, Carerj S, Squadrito G. Abnormal left ventricular global strain during exercise-test in young healthy smokers. Sci Rep. 2020 Mar 30;10(1):5700. doi: 10.1038/s41598-020-62428-7. PMID: 32231243 Free Article
9.   Lo Gullo A, Rodríguez-Carrio J, Gallizzi R, Imbalzano E, Squadrito G, Mandraffino G. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients. Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30057-8. doi: 10.1016/j.pcad.2020.03.005. [Epub ahead of print] Review. PMID: 32201285
10.       Mandraffino G., Scicali R, Rodríguez-Carrio J, Savarino F, Mamone F, Scuruchi M, Cinquegrani M, Imbalzano E, Di Pino A, Piro S, Rabuazzo AM, Squadrito G, Purrello F, Saitta A. Arterial stiffness improvement following adding-on PCSK9 inhibitors or ezetimibe to high intensity statins in familial hypercholesterolemia patients: a two lipid center real-world experience. Journal of Clinical Lipidology. 2020. S1933-2874(20)30015-5. DOI: 10.1016/j.jacl.2020.01.015
11. Scuruchi, M., Potì, F., Rodríguez-Carrio, J., Campo, G.M., Mandraffino, G. Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 2020. 1865(2),158545
12.Avenoso A, Bruschetta G, D Ascola A, Scuruchi M, Mandraffino G, Saitta A, Campo S, Campo GM. Hyaluronan Fragmentation During Inflammatory Pathologies: A Signal That Empowers Tissue Damage. Mini Rev Med Chem. 2020 Sep 6. doi: 20(1), pp. 54-65. PMID: 31490750
13.Avenoso A, Bruschetta G, D'Ascola A, Scuruchi M, Mandraffino G, Gullace R, Saitta A, Campo S, Campo GM. Hyaluronan fragments produced during tissue injury: A signal amplifying the inflammatory response. Arch Biochem Biophys. 2019 Mar 15;663:228-238. doi: 10.1016/j.abb.2019.01.015. Epub 2019 Jan 19. Review. PubMed PMID: 30668938. 
14.Basile G, Catalano A, Mandraffino G, Maltese G, Alibrandi A, Ciancio G, Brischetto D, Morabito N, Lasco A, Cesari M. Frailty modifications and prognostic impact in older patients admitted in acute care. Aging Clin Exp Res. 2019 Jan;31(1):151-155. doi: 10.1007/s40520-018-0989-7. Epub 2018 Jun 26. PubMed PMID:29946755.
15.Scuruchi M, D'Ascola A, Avenoso A, Mandraffino G., Campo S., Campo GM. Serglycin as part of IL-1β induced inflammation in human chondrocytes. Arch Biochem Biophys. 2019 Jul 15;669:80-86. doi: 10.1016/j.abb.2019.05.021. Epub 2019 May 27. PMID: 31145901
16.Mandraffino G, Saitta A. Endothelial and Circulating Progenitor Cells: Between Diseases and Therapies. Curr Med Chem. 2018;25(35):4476-4477. Doi:10.2174/092986732535181026143801. PubMed PMID: 30563440.
17. Imbalzano E, Vatrano M, Ghiadoni L, Mandraffino G, Dalbeni A, Khandheria BK, Costantino R, Trapani G, Manganaro R, Cusmà Piccione M, Carerj S, Ceravolo R, Saitta A, Zito C. Arterial stiffness and mitral regurgitation in arterial hypertension: an intriguing pathophysiological link. Vascul Pharmacol. 2018 Dec;111:71-76. doi: 10.1016/j.vph.2018.10.007. Epub 2018 Oct 22. PubMed PMID:30359778. 
18.       Casula M, Olmastroni E, Pirillo A, Catapano AL; MEMBERS OF THE LIPIGEN STEERING COMMETTEE; PRINCIPAL INVESTIGATORS: Coordinator center; Participant Centers; Participant Laboratories; COLLABORATORS; STUDY CENTRAL LABORATORY AND ANALYSIS GROUP. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study. Atherosclerosis. 2018 Oct;277:413-418. doi: 10.1016/j.atherosclerosis.2018.08.013. PubMed PMID: 30270079.
19.Lo Gullo A, Aragona CO, Scuruchi M, Versace AG, Saitta A, Imbalzano E, Loddo S, Campo GM, Mandraffino G. Endothelial progenitor cells and rheumatic disease modifying therapy. Vascul Pharmacol. 2018 Sep;108:8-14. doi:10.1016/j.vph.2018.05.007. Epub 2018 May 26. Review. PubMed PMID: 29842927.
20.      Muto P, Lo Gullo A, Mandraffino G, Loddo S, Atteritano M. High levels of serum sclerostin and DKK1 in a case of Klippel-Trénaunay syndrome. Osteoporos Int. 2018 Jul;29(7):1679-1681. doi: 10.1007/s00198-018-4563-0. Epub 2018 May 17. PubMed PMID: 29774401.
21.Giardina C, Cutroneo PM, Mocciaro E, Russo GT, Mandraffino G, Basile G, Rapisarda F, Ferrara R, Spina E, Arcoraci V. Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. Front Pharmacol. 2018 Apr 11;9:350. doi: 10.3389/fphar.2018.00350. eCollection 2018. PubMed PMID: 29695966; PubMed Central PMCID: PMC5904209.
22.       D'Ascola A, Scuruchi M, Avenoso A, Bruschetta G, Campo S, Mandraffino G, Campo GM. Serglycin is involved in inflammatory response in articular mouse chondrocytes. Biochem Biophys Res Commun. 2018 May 15;499(3):506-512. doi:10.1016/j.bbrc.2018.03.178. Epub 2018 Mar 31. PubMed PMID: 29588174. 
23.       Lo Gullo A, Rodríguez-Carrio J, Aragona CO, Dattilo G, Zito C, Suárez A, Loddo S, Atteritano M, Saitta A, Mandraffino G. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation. Atherosclerosis. 2018 Apr;271:214-222. doi: 10.1016/j.atherosclerosis.2018.03.004. Epub 2018 Mar 2. PubMed PMID: 29524864.
24.       Imbalzano E, Vatrano M, Quartuccio S, Ceravolo R, Ciconte VA, Rotella P, Pardeo R, Trapani G, De Fazio P, Segura-Garcia C, Costantino R, Saitta A, Mandraffino G. Effect of type D personality on smoking status and their combined impact on outcome after acute myocardial infarction. Clin Cardiol. 2018 Mar;41(3):321-325. doi: 10.1002/clc.22865. Epub 2018 Feb 19. PubMed PMID:29457844.
25.       Avenoso A, D'Ascola A, Scuruchi M, Mandraffino G, Calatroni A, Saitta A, Campo S, Campo GM. Hyaluronan in experimental injured/inflamed cartilage: In vivo studies. Life Sci. 2018 Jan 15;193:132-140. doi: 10.1016/j.lfs.2017.11.006. Epub 2017 Nov 7. Review. PubMed PMID: 29126884.
26.       Avenoso A, D'Ascola A, Scuruchi M, Mandraffino G, Calatroni A, Saitta A, Campo S, Campo GM. The proteoglycan biglycan mediates inflammatory response by activating TLR-4 in human chondrocytes: Inhibition by specific siRNA and high polymerized Hyaluronan. Arch Biochem Biophys. 2018 Jan 13;640:75-82. doi: 10.1016/j.abb.2018.01.007. [Epub ahead of print] PubMed PMID: 29339093.
27.       Avenoso A, D'Ascola A, Scuruchi M, Mandraffino G, Calatroni A, Saitta A, Campo S, Campo GM. Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects. Inflamm Res. 2018 Jan;67(1):5-20. doi: 10.1007/s00011-017-1084-9. Epub 2017 Aug 12. Review. PubMed PMID: 28803264.
28.      Basile G, Catalano A, Mandraffino G, Maltese G, Alibrandi A, Ciancio G, Lasco A, Cesari M. Relationship between blood pressure and frailty in older hypertensive outpatients. Aging Clin Exp Res. 2017 Oct;29(5):1049-1053. doi: 10.1007/s40520-016-0684-5. Epub 2016 Nov 21. PubMed PMID: 27873101.
29.       Pirillo A, Garlaschelli K, Arca M, Averna M, Bertolini S, Calandra S, Tarugi P, Catapano AL; LIPIGEN Group. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study. Atheroscler Suppl. 2017 Oct;29:17-24. doi: 10.1016/j.atherosclerosissup.2017.07.002. PubMed PMID: 28965616.
30.      Averna M, Cefalù AB, Casula M, Noto D, Arca M, Bertolini S, Calandra S, Catapano AL, Tarugi P; LIPIGEN Group. Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN). Atheroscler Suppl. 2017 Oct;29:11-16. doi: 10.1016/j.atherosclerosissup.2017.07.001. PubMed PMID: 28965615. 
31.Oreto L, Mandraffino G, Manuri L, Saitta MB, Agati S, Zito C, Iorio FS, Carerj S, Guccione P. Atrial septal defect morphology and stenting in hypoplastic left heart syndrome after hybrid palliation. Cardiol Young. 2017 Sep 11:1-9. doi: 10.1017/S1047951117001792. [Epub ahead of print] PubMed PMID: 28889828. 
32.       Laufs U, Filipiak KJ, Gouni-Berthold I, Catapano AL; SAMS expert working group (Mandraffino G; Benlian P). Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl. 2017 Apr;26:45-55. doi: 10.1016/S1567-5688(17)30024-7. PubMed PMID: 28434484.
33.       Mandraffino G, Cairo V, Saitta A. Current challenges on circulating progenitor cells: Could their number predict oncoming diseases? Atherosclerosis. 2017 Mar 31. pii: S0021-9150(17)30140-5. doi: 10.1016/j.atherosclerosis.2017.03.037. [Epub ahead of print] PubMed PMID: 28389015.
34.       Mandraffino G, Aragona CO, Scuruchi M, Mamone F, D'Ascola A, Alibrandi A, Cinquegrani M, Morace C, Oreto L, Saitta C, Mormina E, Carerj S, Saitta A, Imbalzano E. Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. Atherosclerosis. 2017 Jan 16;257:109-115. doi: 10.1016/j.atherosclerosis.2017.01.012. [Epub ahead of print] PubMed PMID: 28131044. 
35.       Mandraffino G, Aragona CO, Basile G, Cairo V, Mamone F, Morace C, D'Ascola A, Alibrandi A, Lo Gullo A, Loddo S, Saitta A, Imbalzano E. CD34+ cell count predicts long lasting life in the oldest old. Mech Ageing Dev. 2017 Mar 16. pii: S0047-6374(17)30061-1. doi: 10.1016/j.mad.2017.03.003. [Epub ahead of print] PubMed PMID: 28322848.
36.       Mandraffino G, Aragona CO, Cairo V, Scuruchi M, Lo Gullo A, D'Ascola A, Alibrandi A, Loddo S, Quartuccio S, Morace C, Mormina E, Basile G, Saitta A, Imbalzano E. Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects. PLoS One. 2017 Mar 16;12(3):e0173030. doi: 10.1371/journal.pone.0173030. eCollection 2017. PubMed PMID: 28301500; PubMed Central PMCID: PMC5354372.
37.       Manuri L, Morelli S, Agati S, Saitta MB, Oreto L, Mandraffino G, Iannace E, Iorio FS, Guccione P. Early hybrid approach and enteral feeding algorithm could reduce the incidence of necrotising enterocolitis in neonates with ductus-dependent systemic circulation. Cardiol Young. 2017 Jan;27(1):154-160. doi: 10.1017/S1047951116000275. PubMed PMID: 28281412.
38.      Imbalzano E, Vatrano M, Quartuccio S, Di Stefano R, Aragona CO, Mamone F, D'Ascola A, Scuruchi M, Felice F, Trapani G, Alibrandi A, Ciconte VA, Ceravolo R, Saitta A, Mandraffino G. Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension. Mol Cell Biochem. 2017 Feb 11. doi: 10.1007/s11010-017-2957-5. [Epub ahead of print] PubMed PMID: 28190172.
39.       Lo Gullo A, Mandraffino G, Aragona CO, Molica Colella A, Saitta A, Imbalzano E. Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis. Reumatismo. 2017 Dec 21;69(4):184-188. doi: 10.4081/reumatismo.2017.1013. PMID: 29320845 
40.      Mandraffino G, Aragona CO, Imbalzano E. Surrogate markers of HDL functionality and arterial stiffening: Which role in rheumatoid arthritis? Atherosclerosis. 2016 Jul 5. pii: S0021-9150(16)30301-X. doi: 10.1016/j.atherosclerosis.2016.07.002.
41.Caterina Oriana Aragona, Egidio Imbalzano, Federica Mamone, Valentina Cairo, Alberto Lo Gullo, Angela D’Ascola, Maria Adriana Sardo, Michele Scuruchi, Giorgio Basile, Antonino Saitta, and Giuseppe Mandraffino. Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease, Stem Cells International Volume 2016 (2016), Article ID 8043792, 12 pages; DOI: 10.1155/2016/8043792.
42.       Egidio Imbalzano, Giuseppe Mandraffino, Marco Casciaro, Sebastiano Quartuccio, Antonino Saitta, Sebastiano Gangemi. Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review. Heart Fail Rev. DOI: 10.1007/s10741-016-9529-8.
43.       Lo Gullo A, Aragona CO, Ardesia M, Versace AG, Cascio A, Saitta A, Mandraffino G. A Strongyloides stercoralis infection presenting as arthritis of sternoclavicular joint. Mod Rheumatol. 2016 Nov;26(6):981-983. doi:10.3109/14397595.2015.1132954. Epub 2016 Feb 16. PubMed PMID: 26709048.
44.       Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, Morabito N, Lasco A, Gangemi S, Basile G. Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity. Arch Immunol Ther Exp (Warsz). 2015 Dec 12. [Epub ahead of print] PubMed PMID: 26658771.
45.       Lo Gullo A, Mandraffino G, Bagnato G, Aragona CO, Imbalzano E, D'Ascola A, Rotondo F, Cinquegrani A, Mormina E, Saitta C, Versace AG, Sardo MA, Lo Gullo R, Loddo S, Saitta A. Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number. PLoS One. 2015 Aug 4;10(8):e0134602. doi: 10.1371/journal.pone.0134602. eCollection 2015. PubMed PMID: 26241902; PubMed Central PMCID: PMC4524708.
46.      Imbalzano E, Vatrano M, Mandraffino G, Ghiadoni L, Gangemi S, Bruno RM, Ciconte VA, Paunovic N, Costantino R, Mormina EM, Ceravolo R, Saitta A, Dattilo G. Arterial stiffness as a predictor of recovery of left ventricular systolic function after acute myocardial infarction treated with primary percutaneous coronary intervention. Int J Cardiovasc Imaging. 2015 Dec;31(8):1545-51. doi: 10.1007/s10554-015-0733-8. Epub 2015 Aug 4. PubMed PMID: 26239135.
47.       Basile G, Catalano A, Mandraffino G, Crucitti A, Ciancio G, Morabito N, Lasco A. Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values. J Am Geriatr Soc. 2015 Jun;63(6):1260-1. doi: 10.1111/jgs.13495. PubMed PMID: 26096407.
48.      Vatrano M, Dattilo G, Mandraffino G, Gangemi S, Ciconte VA, Quartuccio S, Ceravolo R, Imbalzano E. A quick bailout ongoing of cardiogenic shock and iatrogenic dissection of the left main coronary artery. Int J Cardiol. 2015 Apr 1;184:473-4. doi: 10.1016/j.ijcard.2015.03.001. Epub 2015 Mar 3. PubMed PMID: 25756567. 
49.       Mandraffino G, Imbalzano E, Mamone F, Aragona CO, Lo Gullo A, D'Ascola A, Alibrandi A, Cinquegrani A, Mormina E, Versace A, Basile G, Sardo MA, Cinquegrani M, Carerj S, Saitta A. Biglycan expression in current cigarette smokers: a possible link between active smoking and atherogenesis. Atherosclerosis. 2014 Dec;237(2):471-9. doi: 10.1016/j.atherosclerosis.2014.10.024. Epub 2014 Oct 18. PubMed PMID: 25463076.
50.      Lo Gullo A, Mandraffino G, Imbalzano E, Mamone F, Aragona CO, D'Ascola A, Loddo S, Cinquegrani A, Alibrandi A, Mormina E, Bagnato G, Lo Gullo R, Sardo MA, Saitta A. Toll-like receptor 3 and interleukin 1β expression in CD34+ cells from patients with rheumatoid arthritis: association with inflammation and vascular involvement. Clin Exp Rheumatol. 2014 Nov-Dec;32(6):922-9. Epub 2014 Nov 7. PubMed PMID: 25436985.
51.Imbalzano E, Scarpelli M, Mandraffino G, Creazzo M, Lizio G, Trapani G, Dattilo G, Dalbeni A, Tomasello C, Sardo MA, Saitta A. Combination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria. J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):956-64. doi: 10.1177/1470320314530018. Epub 2014 Jul 27. PubMed PMID: 25070350.
52.  Imbalzano E, Mandraffino G, Ceravolo R, Di Stefano R, Saitta A. Renal denervation rapidly restores circulating proangiogenic hematopoietic cells in patients affected by drug-resistant hypertension. Int J Cardiol. 2014 May 15;173(3):591-2. doi: 10.1016/j.ijcard.2014.03.100. Epub 2014 Mar 21. PubMed PMID: 24698255.
53.  Imbalzano E, Casale M, D'Angelo M, Mandraffino G, Giugno V, Di Bella G, Carerj S, Dattilo G. Cardiovascular risk and psoriasis: a role in clinical cardiology? Angiology. 2015 Feb;66(2):101-3. doi: 10.1177/0003319714527339. Epub 2014 Mar 25. Review. PubMed PMID: 24671131.
54.  Mandraffino G, Imbalzano E, Sardo MA, D'Ascola A, Mamone F, Lo Gullo A, Alibrandi A, Loddo S, Mormina E, David A, Saitta A. Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement. J Hum Hypertens. 2014 Sep;28(9):543-50. doi: 10.1038/jhh.2014.7. Epub 2014 Feb 20. PubMed PMID: 24553637.
55.  Mandraffino G, Dalbeni A, Paunovic N, Mormina EM, Imbalzano E. Radiation-induced heart and vessel atherosclerosis disease. Int J Cardiol. 2014 Mar 15;172(2):505-6. doi: 10.1016/j.ijcard.2014.01.059. Epub 2014 Jan 23. PubMed PMID: 24485624.
56.  Imbalzano E, Saitta A, Lamari A, Trapani G, Lizio G, Creazzo M, Mandraffino G, Scarano M, Dattilo G. [Echo-Doppler evaluation of recent onset chronic venous insufficiency in elderly patients: does the heart have a role?]. Recenti Prog Med. 2013 Nov;104(11):569-73. doi: 10.1701/1370.15226. Italian. PubMed PMID: 24336618.
57.  Lo Gullo A, Mandraffino G, Sardo MA, D'Ascola A, Mamone F, Loddo S, Alibrandi A, Imbalzano E, Mandraffino R, Mormina E, Saitta C, Lo Gullo R, David A, Saitta A. Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. Scand J Rheumatol. 2014;43(3):184-93. doi: 10.3109/03009742.2013.836564. Epub 2013 Dec 9. PubMed PMID: 24313545.
58. Imbalzano E, Creazzo M, Mandraffino G, Sardo MA, Saitta A. Treatment failure of low molecular weight heparin in post-surgery orthopedic case. Int J Cardiol. 2013 Nov 5;169(3):e36-7. doi: 10.1016/j.ijcard.2013.08.109. Epub 2013 Sep 8. PubMed PMID: 24063927.
59.  Mandraffino G, Sardo MA, Riggio S, D'Ascola A, Alibrandi A, Saitta C, Versace A, Castaldo M, Mormina E, Imbalzano E, Cinquegrani M, Bonaiuto M, David A, Saitta A. Circulating progenitor cells and the elderly: a seven-year observational study. Exp Gerontol. 2012 May;47(5):394-400. doi: 10.1016/j.exger.2012.03.007. Epub 2012 Mar 17. PubMed PMID: 22449458.
60. Imbalzano E, Zito C, Carerj S, Oreto G, Mandraffino G, Cusmà-Piccione M, Di Bella G, Saitta C, Saitta A. Left ventricular function in hypertension: new insight by speckle tracking echocardiography. Echocardiography. 2011 Jul;28(6):649-57. doi: 10.1111/j.1540-8175.2011.01410.x. Epub 2011 Jun 15. PubMed PMID: 21676016.
61.  Mandraffino G, Sardo MA, Riggio S, Loddo S, Imbalzano E, Alibrandi A, Saitta C, Cinquegrani M, Mormina EM, Saitta A. Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. Hypertens Res. 2011 Jul;34(7):876-83. doi: 10.1038/hr.2011.56. Epub 2011 May 19. PubMed PMID: 21593737.
62. Cascio A, Mandraffino G, Cinquegrani M, Delfino D, Mandraffino R, Romeo O, Criseo G, Saitta A. Actinomadura pelletieri mycetoma--an atypical case with spine and abdominal wall involvement. J Med Microbiol. 2011 May;60(Pt 5):673-6. doi: 10.1099/jmm.0.027862-0. Epub 2011 Jan 20. Review. PubMed PMID: 21252272.
63. Mandraffino G, Sardo MA, Riggio S, D'Ascola A, Loddo S, Alibrandi A, Saitta C, Imbalzano E, Mandraffino R, Venza M, Mormina EM, David A, Saitta A. Smoke exposure and circulating progenitor cells: evidence for modulation of antioxidant enzymes and cell count. Clin Biochem. 2010 Dec;43(18):1436-42. doi: 10.1016/j.clinbiochem.2010.09.023. Epub 2010 Sep 29. PubMed PMID: 20888331.
64. Riggio S, Mamone F, Mandraffino G, Maimone S, Alibrandi A, Manti L, Saitta C, Tripodi PF, Sardo MA, Squadrito G, Saitta A. Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. Eur J Clin Invest. 2010 Aug;40(8):722-8. doi: 10.1111/j.1365-2362.2010.02323.x. Epub 2010 Jun 14. PubMed PMID: 20561029.
65.  Sardo MA, Mandraffino G, Riggio S, D'Ascola A, Alibrandi A, Saitta C, Imbalzano E, Castaldo M, Cinquegrani M, Saitta A. Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients. Clin Exp Pharmacol Physiol. 2010 Sep;37(9):933-8. doi: 10.1111/j.1440-1681.2010.05407.x. Epub 2010 May 24. PubMed PMID: 20497421.
66. Riggio S, Mandraffino G, Sardo MA, Iudicello R, Camarda N, Imbalzano E, Alibrandi A, Saitta C, Carerj S, Arrigo T, Saitta A. Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest. 2010 Mar;40(3):250-7. doi: 10.1111/j.1365-2362.2010.02260.x. PubMed PMID: 20415700.
67.  Sardo MA, Mandraffino G, Campo S, Saitta C, Bitto A, Alibrandi A, Riggio S, Imbalzano E, Saitta A. Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. Clin Chim Acta. 2009 Aug;406(1-2):89-93. doi: 10.1016/j.cca.2009.05.024. Epub 2009 Jun 10. PubMed PMID: 19523462.
68.   Sardo MA, Campo S, Mandraffino G, Saitta C, Bonaiuto A, Castaldo M, Cinquegrani M, Pizzimenti G, Saitta A. Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. Clin Chem. 2008 May;54(5):814-23. doi: 10.1373/clinchem.2007.095547. Epub 2008 Mar 13. PubMed PMID: 18339698.
Aknowledgments  
Awarded oral Communication  27th (European) Meeting on Hypertension and Cardiovascular Protection Milan (Italy), June 16-19, 2017 (ESH): Efficacy of monoclonal antibodies anti-proprotein convertase subtilisin-kexin type 9 in improving lipid profile and arterial stiffness in patients affected by familial hypercholesterolemia; Oral Communication
   
Accommodation Grant Prize 26th (European) Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13, 2016 (ESH): “Circulating progenitor cells in hypertension: effectiveness of a treatment with olmesartan in improving cell number and miRs profile besides expected pharmacological effects”
Presenting author
   
Award for Best Poster Session 
“Alberto Ferrari Poster Prize”
26th (European) Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13, 2016 (ESH): “Circulating progenitor cells in hypertension: effectiveness of a treatment with olmesartan in improving cell number and miRs profile besides expected pharmacological effects”
Presenting author
   
Best original contribution Spring Meeting SISA/SIIA, Rimini, 11-12 March, 2016; section: Poster
Contribution: AT1R blockade by Losartan as well as smoking cessation reduce Biglycan expression in uncomplicated subjects
Presenting author
   
Travel Grant Prize EAS European Congress, Innsbruck, May 29- June 1 2016; section: Poster
Three original contributions
Presenting author
   
Travel Grant Prize EAS European Congress, Innsbruck, May 29- June 1 2016; section: Poster
Three original contributions
Co-author
   
Young Researcher Prizes
(SISA Travel Grant)
Edizioni Congresso Nazionale SISA: 2006; 2007; 2009; 2010; 2011; 2012; 2013; 2014; 2015; 2016; 2017; 2018; 2019.
Quattro volte premiato come presenting first author
Sei volte premiato come non-presenting first author (co-primo)
Dieci volte premiato come study coordinator author
Nove volte premiato come non-presenting author
   
Last Update: 
May, 20th, 2021
 
 
Including: autorizzazione al trattamento dei dati personali e la dichiarazione di veridicità dei dati secondo il D.P.R. n.445/2000.
 
 

    Curriculum

         
    Curriculum Vitae    
         
    Personal information    
    First name(s) / Surname(s)  Giuseppe Mandraffino  
    Work Address(es) Dipartimento di Medicina Clinica e Sperimentale
    V. Consolare Valeria Gazzi, University Hospital G. Martino
     
    Telephone(s) +39 0902212359 Mobile:    
    Fax(es) +390902212372  
    E-mail gmandraffino@unime.it or gmandraffinomd@libero.it  
    PEC g.mandraffino-8901@pec.omceo.me.it  
    Nationality Italian  
    Date of birth May 11, 1980  
    Gender Male  
         
    Current position      
    Academic Senior Assistant Professor (Internal Medicine), University of Messina   
         
    Teachings
     
    ·       Single Cycle Master Degree: School of Medicine and Surgery, 
    University of Messina 
     
    ·       Medical Specialization Schools
    ·       Internal Medicine 
    ·       Geriatrics
    ·       Cardiology
    ·       Neurology
    ·       Hematology
    ·       Oftalmology
    ·       Thoracic Surgery 
    ·       Radiology
    ·       Pharmacology and Toxicology –medical course 
    ·       Pharmacology and Toxicology –nonmedical course
     
    ·       PhD Course in Clinical and Experimental Medical Science (XXXII-XXXIII-XXXIV ciclo)
    ·       International PhD Course in Clinical and Experimental Medical Science 
     
    ·       School for specific formation in General Practionery (2018/2021) - Polo di Messina
     
         
    Current teachings (2020-21)
    CdL Medicina e Chirurgia
    University of Messina
    • Internal Medicine (since AA 2014-15, current)
    • Semeiotics e Clinical Methodology (since AA 2015-16, current)
    • Emergency Medicine (since AA 2015-16, current)
     
         
    Terminated teachings
    (AA 2014-2019)
     
    • AA 2016-17 e 2017-18: Rheumatology – CdL Medicina e Chirurgia
    • AA 2016-17 e 2017-18: Rheumatology – CdL Scienze Infermieristiche
    • AA 2017-18: Rheumatology – CdL Fisioterapia
     
         
    Dissertation tutoring   Tutor for 30 Final Dissertations – MD in Medicine and Surgery 
    Tutor for 3 Final Dissertations – Specialization School in Internal Medicine
    Tutor for 1 Final Dissertation – MD in Nursing 
     
    Academic tasks
    (since 26.02.2018)
    International Mobility Program, Master Degree in Medicine and Surgery   
         
    Assistential Lipigen Lipid Center of Messina, Head; Unit of Internal Medicine  
         
    Formation    
    2009-2012  
    PhD  
    Clinical and Experimental Medicine [XXV ciclo]  
    University of Messina
       
    2004-2009
    Internal Medicine Specialist  
    University of Messina  
       
    1998-2004
    MD, Medical Doctor  
    Master Degree in Medicine and Surgery   
    University of Messina
       
       
    Personal skills and competences    
    Mother tongue(s) Italian  
    Other language(s) English, French  
    Self-assessment   Understanding Speaking Writing
    European level (*)   Listening Reading Spoken interaction Spoken production  
    English     C1   C2   C2   C2   C2
    French     B1   C1   B1   A2   A1
      (*) Common European Framework of Reference for Languages  
         
    Expert Panel APEX (Atherosclerosis Prevention Scientific Exchange), member for “Practical aspects in the management of statin associated muscle symptoms (SAMS)” *
    *Laufs U, Filipiak KJ, Gouni-Berthold I, Catapano AL; SAMS expert working
    group (Mandraffino G; Benlian P.). Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl. 2017 Apr; 26:45-55. doi: 10.1016/S1567-5688(17)30024-7. PMID: 28434484.
     
         
    Advisory Board ·       “The clinical relevance of Odissey Outcomes data in real life”; Web Conference, 9 maggio 2019 - SANOFI
    ·       “L'acido Bempedoico come nuova opzione nel trattamento delle dislipidemie”, 26 Novembre 2020 – DAICHI-SANKYO 
    ·       “Q&A con l’HCP”; 15.01.2021 – NOVONORDISK 
     
       
         
    Scientific Societies membership SISA/EAS; SIMI; ESH.  
         
    Societies board member SISA (sez. “Siculo-Calabra”) (2015-2018, 2018-current)
    SISA – “GRUPPO GIOVANI” – National Board (former, 2016-2019) 
    SIMI (sez. Sicilia) (2019 – attuale)
     
         
    Scientific activities,
     (briefly) 

     
    Speaker/Chairman/Faculty at National, Regional and Interregional meetings by National and International Scientific Societies (SISA; SIMI, AMD/SID, SIC, AICPR, SIPMEL, EAS, ESH).
     
    Scientific Committee for several scientific meetings: SISA National meetings, SISA Young Investigators meetings, SISA Siculo-Calabro meetings (both local and National coverage) 
     
    SIMI Sicily regional meetings, organization
     
    Active SISA member since 2004; author/co-author of more than 70 original contributions so far, accepted as oral communication or poster presentation at National meetings (SISA National meeting; Spring Meeting).
     
    Speaker/Lecturer in a number of training course for medical specialists and/or general practitioners on cardiovascular risk and dyslipidemia, including CME
     
         
    Journal Editorial Board  
         
    Peer Reviewing Activity
    • Ageing [ONLINE ISSN: 1945-4589]
    • Atherosclerosis [ISSN:0021-9150 (Print); 1879-1484 (Electronic); 0021-9150 (Linking)]
    • Biomedicine [EISSN 2227-9059, Published by MDPI]
    • Biomolecules [EISSN 2218-273X, Published by MDPI]
    • BMJ Open [ISSN 2044-6055]
    • British Journal of Medicine and Medical Research [ISSN: 2231-0614]
    • Cardiology Research and Practice [ISSN: 2090-8016 (Print); 2090-0597 (Online)]
    • Cardiovascular Diabetology [ISSN: 1475-2840]
    • Cell Transplantation: The Regenerative Medicine Journal [ISSN: 0963-6897; E-ISSN: 1555-3892]
    • Clinical and Experimental Pharmacology and Physiology [ISSN: 1440-1681 - Online] 
    • Disease Markers: [ISSN: 0278-0240 (Print), ISSN: 1875-8630 (Online)]
    • European Heart Journal [ISSN: 0195-668X]
    • European Journal of Preventive Cardiology [ISSN: 2047-4873 - Online ISSN: 2047-4881]
    • Experimental and Therapeutic Medicine [ISSN: 1792-0981 - eISSN: 1792-1015]
    • Frontiers in Cardiovascular Medicine [ISSN: 2297-055X]
    • Hypertension Research [ISSN:0916-9636 -Print; 1348-4214 -Electronic; 0916- 9636 Linking] 
    • International Journal of Cardiology [ISSN: 0167-5273]
    • International Journal of Molecular Medicine [Print ISSN: 1107-3756; Online ISSN: 1791-244X]
    • International Journal of Molecular Science [EISSN 1422-0067, Published by MDPI ]
    • International Journal of Rheumatic Diseases [ISSN: 1756-185X]
    • Journal of Clinical Lipidology [ISSN: 1933-2874] 
    • Journal of Human Hypertension [ISSN: 0950-9240 –Print; 1476-5527 - Electronic;0950-9240 –Linking] 
    • Medical Principles and Practice [ISSN: 1011-7571 (Print) e-ISSN: 1423-0151 (Online)]
    • Medicine [ISSN: 0025-7974 - Online ISSN: 1536-5964]
    • Molecular and Cellular Biochemistry [ISSN: 0300-8177 (print); ISSN: 1573-4919 (electronic)
    • Nicotine and Tobacco Research [ISSN 1462-2203 –Print; 1469-994X – Electronic; 1462-2203 Linking] 
    • Nutrition [ISSN: 0899-9007]
    • Nutrition Metabolism and Cardiovascular Disease [ISSN: 0939-4753]
    • Oncotarget [ISSN: 1949-2553]
    • PLOS one [ISSN: 1932-6203 –Electronic; 1932-6203 Linking] 
    • Rheumatology [Online ISSN 1462-0332 - Print ISSN 1462-0324]
    • Scandinavian Journal of Rheumatology [ISSN 0300-9742 (Print), 1502-7732 (Online)] 
    • Scientifica: [ISSN 2090-908X (Online)] 
    • The Open Rheumatology Journal [ISSN: 1874-3129]
     
         
    Current investigations Main research focus: 
    Lipids interaction with other cardiovascular risk factors: vascular and cardiac clinical and subclinical damage; mediators, markers, outcomes. 
    • Endocan plasma levels in patients with Cardiovascular risk factors 
    • Endocan plasma levels in patients with Rheumatoid arthritis
    • Endocan plasma levels in patients with Psoriatic arthritis
    • MicroRNA levels in patients with different conditions characterized by high cardiovascular risk
    • MicroRNA before and after pharmacologic treatment
    • CD34+ cells in peripheral blood in patients with different conditions characterized by high cardiovascular risk
    • CD34+ cells in peripheral blood before and after pharmacologic treatment
    • Lp(a) in different clinical conditions (metabolic syndrome, pregnancy, hyperlipidemia) 
    • Lp(a) change during last frontier therapies: antiPCSK9 monoclonal antibodies
    • Treatment with iPCSK9 and change in vascular mechanical properties, CD34+ cell number, vascular damage and signal molecules.
    • Treatment with Sacubitril/valsartan and change in subtle mechanical properties of left ventricle
     
         
                                 
     

     
    Invited speaker
    (Scientific Societies)

     
    1. SIMI: VIII Congresso Regionale Della Societa’ Italiana Di Medicina Interna Sezione Sicilia – Messina–8-9 Novembre 2019
      • Lettura: “Inibitori di PCSK9: è tempo di ripensare al goal terapeutico?”
    2. IV Congresso Congiunto AMD-SID Sicilia 2019 – 24-25 Ottobre 2019
    V SESSIONE SID: Nuovi anticoagulanti orali e terapia antiaggregante nel diabete 
    • Lettura: I nuovi anticoagulanti orali
    1. SIC: “Prevenzione e trattamento delle malattie cardiovascolari”
      • Lettura “Ipercolesterolemia, quale ruolo per gli integratori?”. Roma 17-18 settembre 2019
    2. SISA 32° congresso nazionale; Sessione: Nuovi biomarcatori e target di danno ateromasico 
      • Lettura “Cellule progenitrici circolanti e proteoglicani”. Bologna, 25-27/11/2018
    3. SISA-SIIA-SIMI: Relazione su invito Spring Meeting Giovani Ricercatori SIIA, SIMI, SISA - Evento Intersocietario a carattere Nazionale Tavola rotonda "Forthcoming Projects" – Rimini 6-7 Aprile 2018
      • Lettura: “Il Progetto Lipigen”
    4. SIMI: VII Congresso Regionale Della Societa’ Italiana Di Medicina Interna Sezione Sicilia – Cefalù – 1-2 Dicembre 2017
      • Lettura: “Gestione clinica del paziente ad alto rischio”
    5. SISA: Congresso annuale della sezione siculo-calabra della Società Italiana dell’Aterosclerosi – Castel di Tusa, 9 ottobre 2017
      • Lettura: “Cellule progenitrici circolanti e patologia cardiovascolare: cose c’è di nuovo?”
    6. SIC-SIEC: XIV International Meeting of Echocardiography. Hilton Giardini Naxos - October, 6–8, 2016
      • Lettura: “Treatment of arterial hypertension: state of the art”
    7. SIMI: La Medicina Interna: ricerca, evidenze scientifiche e metodologia clinica; Vibo Valentia - April, 19-21, 2007.
      • Lettura: “Le ipolipidemie sono sempre protettive?”
    8. AICPR – Associazione Italiana di Cardiologia Clinica, Preventiva e Riabilitativa, 11 Congresso regionale, 11.05.2019, Messina
      • Lettura: ESC 2017: novità nella gestione del paziente con fibrillazione atriale
    9. SIPMEL – Società Italiana di Patologia medica e Medicina di Laboratorio - sez reg Siciliana – 25 maggio 2018
      • Lettura: Individuazione di marcatori predittivi di efficacia e di sanguinamento
    10. SISA (patr.): “Dislipidemie familiari: un iceberg da scoprire”; I edizione – Messina 12 maggio 2012 
      • Lettura: Dislipidemie familiari e Ipercolesterolemia
      • Lettura: Screening dei pazienti: metodi e strumenti
      • Lettura: Prescrizione: Nota 13 (prima parte)
    11. SISA (patr.): “Dislipidemie familiari, un iceberg da scoprire”; II edizione – Giardini Naxos (ME) 3 novembre 2012 
      • Lettura: Dislipidemie familiari e Ipercolesterolemia
      • Lettura: Screening dei pazienti: metodi e strumenti
      • Lettura: Prescrizione: Nota 13 (prima parte)
    12. SISA (patr.): La prevenzione nel paziente a rischio cardiovascolare: Facciamo tutti il possibile?” Messina - October, 24, 2015
      • Lettura: “Il paziente ad elevato rischio CV: Aspetti pratici”
    13. SISA-SIIA: Spring Meeting Giovani Ricercatori, Rimini - March, 11-12, 2016
      • Lettura: “Change in miRs 145, 221 and 222 expression in hypertensive subjects treated with enalapril, losartan or olmesartan”
    14. ESH26th (European) Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13, 2016 (European Society of Hypertension)
      • Lettura: “Circulating progenitor cells in hypertension: effectiveness of a treatment with olmesartan in improving cell number and miRs profile besides expected pharmacological effects”
    Lo slot come Lettura è stato parte del premio conseguito nella sessione poster nel contesto dell’evento (Alberto Ferrari Poster Prize)
    1. SISA (patr.): “Before, Il controllo della dislipidemia nella prevenzione CV” – Messina, 20 maggio 2017 (anche Responsabile scientifico)
      • Lettura“Dislipidemia e Aterosclerosi”
     
    Leadership or participation in cooperative panels , including international  
    ·     Local Principal investigator for multicentic the study: Treatment of High and Very high riSk dysplipidemic pAtients for the PreveNTion of cardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI) (CE 45-20, November, 11th, 2020)
    ·     Local Principal investigator for multicentic the study: LIPIGEN, (Lipid TransPort Disorders Italian Genetic Network)
     Supported by
    : Società Italiana per lo Studio dell'Arteriosclerosi (SISA); Fondazione SISA
    ; publication list :

    1: Pirillo A et al; Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study. Atheroscler Suppl. 2017 Oct;29:17-24. doi: 10.1016/j.atherosclerosissup.2017.07.002. PubMed PMID: 28965616.
    2: Averna M et al; LIPIGEN Group. Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN). Atheroscler Suppl. 2017 Oct;29:11-16. doi: 10.1016/j.atherosclerosissup.2017.07.001. PubMed PMID: 28965615.
    3: Casula M. et al; Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study. Atherosclerosis. 2018 Oct;277:413-418. doi: 10.1016/j.atherosclerosis.2018.08.013.
    dal 16-06-2016 a oggi
    ·     Local Principal investigator for multicentic the study: PROSISA, (Project Statin Intolerance SISA)
     Supported by Società Italiana per lo Studio dell'Arteriosclerosi (SISA); Fondazione SISA. CE 115/16. Publication list:
    1.     M Casula, M Gazzotti, F Bonaiti, E OImastroni, M Arca, M Averna, A Zambon, A L Catapano, PROSISA Study Group Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study. J Intern Med. 2020 Dec 1. doi: 10.1111/joim.13219
    dal 08-11-2016 a oggi 
    ·     Participation, National Research Group [Dipartimento di Terapia Intensiva Pediatrica dell'Ospedale Bambino Gesù (Roma), il Centro Mediterraneo di Cardiologia Pediatrica dell'Ospedale Bambino Gesù (Taormina), ed il Dipartimento di Medicina Clinica e Sperimentale dell'Università degli Studi di Messina (Cardiologia e Medicina Interna)]. Publication list:
     
    1.     Oreto L, Mandraffino G, et al; Atrial septal defect morphology and stenting in hypoplastic left heart syndrome after hybrid palliation. Cardiol Young. 2018 Feb;28(2):252-260.

    2.     Manuri L, ..., Mandraffino G, et al; Early hybrid approach and enteral feeding algorithm could reduce the incidence of necrotising enterocolitis in neonates with ductus-dependent systemic circulation. Cardiol Young. 2017 Jan;27(1):154-160.
     

    dal 01-10-2015 a oggi 
    ·     Particpation, National Research Group ad un [Centro Nemo (NEuroMuscular Omnicentre) ed il Dipartimento di Medicina Clinica e Sperimentale dell'Università degli Studi di Messina (Cardiologia, Medicina Interna)
    ]
    Publication list: 
    1.     Oreto L, Vita GL, Mandraffino G, Carerj S, Calabrò MP, Manganaro R, Cusmà-Piccione M, Todaro MC, Sframeli M, Cinquegrani M, Toscano A, Vita G, Messina S, Zito C., Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance; Acta Myol. 2020 Dec 1;39(4):191-199.  doi: 10.36185/2532-1900-022. 

    dal 01-10-2016 a oggi 
    ·     Member, <<SAMS Expert Working Group>>, panel for the management of muscular symptoms onset during statin treatment. 
    Consensus Paper: 
    1.     Laufs U et al. Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl. 2017 Apr; 26:45-55. doi: 10.1016/S1567-5688(17)30024-7. PubMed PMID: 28434484 (2015-2017).
    ·     Participation, pharmacological surveillance “FORWARD” (Facilitation of reporting in hospital Ward) 

    publication list 
    1.     Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. C Giardina, ..., G Mandraffino, et al. Frontiers in Pharmacology 2018: 9, 350. doi: 10.3389/fphar.2018.00350
    FORWARD: Programma per lo sviluppo del Servizio Sanitario Regionale 2010; Sede direzionale Policlinico Universitario di Messina G. Martino; responsabile del progetto: prof. Vincenzo Arcoraci 
    dal 01-06-2016 a oggi 
    ·     Partecipazione ad un Gruppo di Ricerca Nazionale che vede coinvolti: Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Messina (Medicina Interna, Cardiologia), Cardiologia con UTIC dell'Ospedale Pugliese-Ciaccio di Catanzaro; Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Pisa; Dipartimento di Medicina Interna dell'Università di Verona. 
    Ad oggi l'attività di ricerca del gruppo ha prodotto 6 pubblicazioni a stampa su riviste di rilevanza internazionale (vedi allegato) 
    dal 01-09-2013 a oggi 
    ·     LIPIGEN supporting for the study: POSTER (PREVALENCE OF FAMILIAL HYPERCOLESTEROLAEMIA (FH) IN ITALIAN PATIENTS WITH CORONARY ARTERY DISEASE) (promoted by ANMCO and SISA). 
    2016-2018 
    ·     Coordination, “Gruppo Giovani Ricercatori SISA”: participation (including Board member) to the National Research group. 
    Main topic: "Novità nello studio dell'Aterosclerosi e sue complicanze"
    URL: http://www.sisa.it/index.php?class=Comp& className=Content&op=Show¶m=cid,958, preview,0
    .
    ·     Principal Investigator Center 33017 (Messina) studio multicentrico osservazionale <<20130296>>, "Site Evaluation" , prot CE interaziendale n 15/17 
    dal 20-02-2017 a oggi 
    ·     “Unravelling the links among lipid metabolism, immune system and vascular damage in chronic conditions: towards novel biomarkers and therapeutic targets” (reference PI19/00081) submitted by Prof. Dr. Ana Suárez Díaz from the University of Oviedo to the Instituto de Salud Carlos III (Acción Estratégica en Salud 2019) University of Messina - Dipartimento di Medicina Clinica e Sperimentale, Dott. Javier Rodriguez-Carrìo, Prof. Ana Suarez dell’Università di Oviedo.
    ·     Leadership of an International Research group entitled: "New markers of preclinical cardiovascular impairment in chronic inflammatory disease";
     Dipartimento di Medicina Clinica e Sperimentale dell'Università degli Studi di Messina (Medicina Interna, Laboratorio di Biochimica e Biologia Molecolare), Area of Immunology, Department of Functional Biology, Faculty of Medicine, University of Oviedo, Oviedo, Spain [Coll: Javier Rodriguez-Carrìo, MSc, PhD; Ana Suarez, Profesor asociado]

    Publication list:
    ·     1. Lo Gullo A, Rodríguez-Carrio J, Gallizzi R, Imbalzano E, Squadrito G, Mandraffino G. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients. Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30057-8. doi: 10.1016/j.pcad.2020.03.005. [Epub ahead of print] Review. PubMed PMID: 32201285.
    2. Lo Gullo A, Rodríguez-Carrio J, Aragona CO, Dattilo G, Zito C, Suárez A, Loddo S, Atteritano M, Saitta A, Mandraffino G. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation. Atherosclerosis. 2018 Apr;271:214-222. doi: 10.1016/j.atherosclerosis.2018.03.004. Epub 2018 Mar 2. PubMed PMID: 29524864.
    3: Mandraffino G, Scicali R, Rodríguez-Carrio J, Savarino F, Mamone F, Scuruchi M, Cinquegrani M, Imbalzano E, Di Pino A, Piro S, Rabuazzo AM, Squadrito G, Purrello F, Saitta A. Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience. J Clin Lipidol. 2020 Feb 4. pii: S1933-2874(20)30015-5. doi: 10.1016/j.jacl.2020.01.015. [Epub ahead of print] PubMed PMID: 32111581.
    4: Scuruchi M, Potì F, Rodríguez-Carrio J, Campo GM, Mandraffino G. Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158545. doi: 10.1016/j.bbalip.2019.158545. Epub 2019 Oct 28. Review. PubMed PMID: 31672572. altri dati preliminari sono stati inviati in forma di contributo originale del gruppo di ricerca (abstracts) e accettati a congressi di Società scientifiche nazionale (SISA/SIIA/SIMI, Spring meeting intersocietario 2020) ed internazionali (EAS 2020; EULAR 2020). 

    dal 14-08-2017 a oggi 
       
     
    Published articles 68 (source: Pubmed, Scopus) – May, 20th, 2021.
       
    Metrics Impact Factor: >200 (Clarivate Analytics); 
    H-index: 19; citations: 1059 (source: Scopus)
       
    Publication List
    (International peer-reviewed Journals)
    1.   Scuruchi, M., D’Ascola, A, Avenoso, A, Mandraffino, G., Campo, S., Campo, G.M., Endocan, a novel inflammatory marker, is upregulated in human chondrocytes stimulated with IL-1 beta. Molecular and Cellular Biochemistry; Volume 476, Issue 3, March 2021, Pages 1589-1597
    2.   Lilia Oreto, Gian Luca Vita, Giuseppe Mandraffino, Scipione Carerj, Maria Pia Calabrò, Roberta Manganaro, Maurizio Cusmà-Piccione, Maria Chiara Todaro, Maria Sframeli, Maria Cinquegrani, Antonio Toscano, Giuseppe Vita, Sonia Messina, Concetta Zito. Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance. Acta Myol. 2020 Dec 1;39(4):191-199. doi: 10.36185/2532-1900-022. eCollection 2020 Dec.
    3.   Avenoso A, Campo S, Scuruchi M, Mania M, Innao V, D'Ascola A, Mandraffino G, Allegra AG, Musolino C, Allegra A. Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects. Pathol Res Pract. 2020 Dec 13;218:153317. doi: 10.1016/j.prp.2020.153317. Online ahead of print.PMID: 33360970
    4.   Casula M, Gazzotti M, Bonaiti F, OImastroni E, Arca M, Averna M, Zambon A, Catapano AL; PROSISA Study Group. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study. J Intern Med. 2020 Dec 1. doi: 10.1111/joim.13219. Online ahead of print. PMID: 33259671
    5.   D'Ascola A, Scuruchi M, Ruggeri RM, Avenoso A, Mandraffino G, Vicchio TM, Campo S, Campo GM. Hyaluronan oligosaccharides modulate inflammatory response, NIS and thyreoglobulin expression in human thyrocytes. Arch Biochem Biophys. 2020 Nov 15;694:108598. doi: 10.1016/j.abb.2020.108598. Epub 2020 Sep 22. PMID: 32976824
    6.   Avenoso A, D'Ascola A, Scuruchi M, Mandraffino G, Campo S, Campo GM. miR146a up-regulation is involved in small HA oligosaccharides-induced pro-inflammatory response in human chondrocytes. Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129731. doi: 10.1016/j.bbagen.2020.129731. Epub 2020 Sep 12. PMID: 32931869
    7.   Mandraffino, G., Scicali, R., Squadrito, G. Author's reply to: Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia, a letter from Papaioannou and colleagues. Journal of Clinical Lipidology, 2020. Volume 14, Issue 4, July - August 2020, Page 543
    8.  Mandraffino G, Imbalzano E, Lo Gullo A, Zito C, Morace C, Cinquegrani M, Savarino F, Oreto L, Giuffrida C, Carerj S, Squadrito G. Abnormal left ventricular global strain during exercise-test in young healthy smokers. Sci Rep. 2020 Mar 30;10(1):5700. doi: 10.1038/s41598-020-62428-7. PMID: 32231243 Free Article
    9.   Lo Gullo A, Rodríguez-Carrio J, Gallizzi R, Imbalzano E, Squadrito G, Mandraffino G. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients. Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30057-8. doi: 10.1016/j.pcad.2020.03.005. [Epub ahead of print] Review. PMID: 32201285
    10.       Mandraffino G., Scicali R, Rodríguez-Carrio J, Savarino F, Mamone F, Scuruchi M, Cinquegrani M, Imbalzano E, Di Pino A, Piro S, Rabuazzo AM, Squadrito G, Purrello F, Saitta A. Arterial stiffness improvement following adding-on PCSK9 inhibitors or ezetimibe to high intensity statins in familial hypercholesterolemia patients: a two lipid center real-world experience. Journal of Clinical Lipidology. 2020. S1933-2874(20)30015-5. DOI: 10.1016/j.jacl.2020.01.015
    11. Scuruchi, M., Potì, F., Rodríguez-Carrio, J., Campo, G.M., Mandraffino, G. Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 2020. 1865(2),158545
    12.Avenoso A, Bruschetta G, D Ascola A, Scuruchi M, Mandraffino G, Saitta A, Campo S, Campo GM. Hyaluronan Fragmentation During Inflammatory Pathologies: A Signal That Empowers Tissue Damage. Mini Rev Med Chem. 2020 Sep 6. doi: 20(1), pp. 54-65. PMID: 31490750
    13.Avenoso A, Bruschetta G, D'Ascola A, Scuruchi M, Mandraffino G, Gullace R, Saitta A, Campo S, Campo GM. Hyaluronan fragments produced during tissue injury: A signal amplifying the inflammatory response. Arch Biochem Biophys. 2019 Mar 15;663:228-238. doi: 10.1016/j.abb.2019.01.015. Epub 2019 Jan 19. Review. PubMed PMID: 30668938. 
    14.Basile G, Catalano A, Mandraffino G, Maltese G, Alibrandi A, Ciancio G, Brischetto D, Morabito N, Lasco A, Cesari M. Frailty modifications and prognostic impact in older patients admitted in acute care. Aging Clin Exp Res. 2019 Jan;31(1):151-155. doi: 10.1007/s40520-018-0989-7. Epub 2018 Jun 26. PubMed PMID:29946755.
    15.Scuruchi M, D'Ascola A, Avenoso A, Mandraffino G., Campo S., Campo GM. Serglycin as part of IL-1β induced inflammation in human chondrocytes. Arch Biochem Biophys. 2019 Jul 15;669:80-86. doi: 10.1016/j.abb.2019.05.021. Epub 2019 May 27. PMID: 31145901
    16.Mandraffino G, Saitta A. Endothelial and Circulating Progenitor Cells: Between Diseases and Therapies. Curr Med Chem. 2018;25(35):4476-4477. Doi:10.2174/092986732535181026143801. PubMed PMID: 30563440.
    17. Imbalzano E, Vatrano M, Ghiadoni L, Mandraffino G, Dalbeni A, Khandheria BK, Costantino R, Trapani G, Manganaro R, Cusmà Piccione M, Carerj S, Ceravolo R, Saitta A, Zito C. Arterial stiffness and mitral regurgitation in arterial hypertension: an intriguing pathophysiological link. Vascul Pharmacol. 2018 Dec;111:71-76. doi: 10.1016/j.vph.2018.10.007. Epub 2018 Oct 22. PubMed PMID:30359778. 
    18.       Casula M, Olmastroni E, Pirillo A, Catapano AL; MEMBERS OF THE LIPIGEN STEERING COMMETTEE; PRINCIPAL INVESTIGATORS: Coordinator center; Participant Centers; Participant Laboratories; COLLABORATORS; STUDY CENTRAL LABORATORY AND ANALYSIS GROUP. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study. Atherosclerosis. 2018 Oct;277:413-418. doi: 10.1016/j.atherosclerosis.2018.08.013. PubMed PMID: 30270079.
    19.Lo Gullo A, Aragona CO, Scuruchi M, Versace AG, Saitta A, Imbalzano E, Loddo S, Campo GM, Mandraffino G. Endothelial progenitor cells and rheumatic disease modifying therapy. Vascul Pharmacol. 2018 Sep;108:8-14. doi:10.1016/j.vph.2018.05.007. Epub 2018 May 26. Review. PubMed PMID: 29842927.
    20.      Muto P, Lo Gullo A, Mandraffino G, Loddo S, Atteritano M. High levels of serum sclerostin and DKK1 in a case of Klippel-Trénaunay syndrome. Osteoporos Int. 2018 Jul;29(7):1679-1681. doi: 10.1007/s00198-018-4563-0. Epub 2018 May 17. PubMed PMID: 29774401.
    21.Giardina C, Cutroneo PM, Mocciaro E, Russo GT, Mandraffino G, Basile G, Rapisarda F, Ferrara R, Spina E, Arcoraci V. Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. Front Pharmacol. 2018 Apr 11;9:350. doi: 10.3389/fphar.2018.00350. eCollection 2018. PubMed PMID: 29695966; PubMed Central PMCID: PMC5904209.
    22.       D'Ascola A, Scuruchi M, Avenoso A, Bruschetta G, Campo S, Mandraffino G, Campo GM. Serglycin is involved in inflammatory response in articular mouse chondrocytes. Biochem Biophys Res Commun. 2018 May 15;499(3):506-512. doi:10.1016/j.bbrc.2018.03.178. Epub 2018 Mar 31. PubMed PMID: 29588174. 
    23.       Lo Gullo A, Rodríguez-Carrio J, Aragona CO, Dattilo G, Zito C, Suárez A, Loddo S, Atteritano M, Saitta A, Mandraffino G. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation. Atherosclerosis. 2018 Apr;271:214-222. doi: 10.1016/j.atherosclerosis.2018.03.004. Epub 2018 Mar 2. PubMed PMID: 29524864.
    24.       Imbalzano E, Vatrano M, Quartuccio S, Ceravolo R, Ciconte VA, Rotella P, Pardeo R, Trapani G, De Fazio P, Segura-Garcia C, Costantino R, Saitta A, Mandraffino G. Effect of type D personality on smoking status and their combined impact on outcome after acute myocardial infarction. Clin Cardiol. 2018 Mar;41(3):321-325. doi: 10.1002/clc.22865. Epub 2018 Feb 19. PubMed PMID:29457844.
    25.       Avenoso A, D'Ascola A, Scuruchi M, Mandraffino G, Calatroni A, Saitta A, Campo S, Campo GM. Hyaluronan in experimental injured/inflamed cartilage: In vivo studies. Life Sci. 2018 Jan 15;193:132-140. doi: 10.1016/j.lfs.2017.11.006. Epub 2017 Nov 7. Review. PubMed PMID: 29126884.
    26.       Avenoso A, D'Ascola A, Scuruchi M, Mandraffino G, Calatroni A, Saitta A, Campo S, Campo GM. The proteoglycan biglycan mediates inflammatory response by activating TLR-4 in human chondrocytes: Inhibition by specific siRNA and high polymerized Hyaluronan. Arch Biochem Biophys. 2018 Jan 13;640:75-82. doi: 10.1016/j.abb.2018.01.007. [Epub ahead of print] PubMed PMID: 29339093.
    27.       Avenoso A, D'Ascola A, Scuruchi M, Mandraffino G, Calatroni A, Saitta A, Campo S, Campo GM. Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects. Inflamm Res. 2018 Jan;67(1):5-20. doi: 10.1007/s00011-017-1084-9. Epub 2017 Aug 12. Review. PubMed PMID: 28803264.
    28.      Basile G, Catalano A, Mandraffino G, Maltese G, Alibrandi A, Ciancio G, Lasco A, Cesari M. Relationship between blood pressure and frailty in older hypertensive outpatients. Aging Clin Exp Res. 2017 Oct;29(5):1049-1053. doi: 10.1007/s40520-016-0684-5. Epub 2016 Nov 21. PubMed PMID: 27873101.
    29.       Pirillo A, Garlaschelli K, Arca M, Averna M, Bertolini S, Calandra S, Tarugi P, Catapano AL; LIPIGEN Group. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study. Atheroscler Suppl. 2017 Oct;29:17-24. doi: 10.1016/j.atherosclerosissup.2017.07.002. PubMed PMID: 28965616.
    30.      Averna M, Cefalù AB, Casula M, Noto D, Arca M, Bertolini S, Calandra S, Catapano AL, Tarugi P; LIPIGEN Group. Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN). Atheroscler Suppl. 2017 Oct;29:11-16. doi: 10.1016/j.atherosclerosissup.2017.07.001. PubMed PMID: 28965615. 
    31.Oreto L, Mandraffino G, Manuri L, Saitta MB, Agati S, Zito C, Iorio FS, Carerj S, Guccione P. Atrial septal defect morphology and stenting in hypoplastic left heart syndrome after hybrid palliation. Cardiol Young. 2017 Sep 11:1-9. doi: 10.1017/S1047951117001792. [Epub ahead of print] PubMed PMID: 28889828. 
    32.       Laufs U, Filipiak KJ, Gouni-Berthold I, Catapano AL; SAMS expert working group (Mandraffino G; Benlian P). Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl. 2017 Apr;26:45-55. doi: 10.1016/S1567-5688(17)30024-7. PubMed PMID: 28434484.
    33.       Mandraffino G, Cairo V, Saitta A. Current challenges on circulating progenitor cells: Could their number predict oncoming diseases? Atherosclerosis. 2017 Mar 31. pii: S0021-9150(17)30140-5. doi: 10.1016/j.atherosclerosis.2017.03.037. [Epub ahead of print] PubMed PMID: 28389015.
    34.       Mandraffino G, Aragona CO, Scuruchi M, Mamone F, D'Ascola A, Alibrandi A, Cinquegrani M, Morace C, Oreto L, Saitta C, Mormina E, Carerj S, Saitta A, Imbalzano E. Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. Atherosclerosis. 2017 Jan 16;257:109-115. doi: 10.1016/j.atherosclerosis.2017.01.012. [Epub ahead of print] PubMed PMID: 28131044. 
    35.       Mandraffino G, Aragona CO, Basile G, Cairo V, Mamone F, Morace C, D'Ascola A, Alibrandi A, Lo Gullo A, Loddo S, Saitta A, Imbalzano E. CD34+ cell count predicts long lasting life in the oldest old. Mech Ageing Dev. 2017 Mar 16. pii: S0047-6374(17)30061-1. doi: 10.1016/j.mad.2017.03.003. [Epub ahead of print] PubMed PMID: 28322848.
    36.       Mandraffino G, Aragona CO, Cairo V, Scuruchi M, Lo Gullo A, D'Ascola A, Alibrandi A, Loddo S, Quartuccio S, Morace C, Mormina E, Basile G, Saitta A, Imbalzano E. Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects. PLoS One. 2017 Mar 16;12(3):e0173030. doi: 10.1371/journal.pone.0173030. eCollection 2017. PubMed PMID: 28301500; PubMed Central PMCID: PMC5354372.
    37.       Manuri L, Morelli S, Agati S, Saitta MB, Oreto L, Mandraffino G, Iannace E, Iorio FS, Guccione P. Early hybrid approach and enteral feeding algorithm could reduce the incidence of necrotising enterocolitis in neonates with ductus-dependent systemic circulation. Cardiol Young. 2017 Jan;27(1):154-160. doi: 10.1017/S1047951116000275. PubMed PMID: 28281412.
    38.      Imbalzano E, Vatrano M, Quartuccio S, Di Stefano R, Aragona CO, Mamone F, D'Ascola A, Scuruchi M, Felice F, Trapani G, Alibrandi A, Ciconte VA, Ceravolo R, Saitta A, Mandraffino G. Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension. Mol Cell Biochem. 2017 Feb 11. doi: 10.1007/s11010-017-2957-5. [Epub ahead of print] PubMed PMID: 28190172.
    39.       Lo Gullo A, Mandraffino G, Aragona CO, Molica Colella A, Saitta A, Imbalzano E. Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis. Reumatismo. 2017 Dec 21;69(4):184-188. doi: 10.4081/reumatismo.2017.1013. PMID: 29320845 
    40.      Mandraffino G, Aragona CO, Imbalzano E. Surrogate markers of HDL functionality and arterial stiffening: Which role in rheumatoid arthritis? Atherosclerosis. 2016 Jul 5. pii: S0021-9150(16)30301-X. doi: 10.1016/j.atherosclerosis.2016.07.002.
    41.Caterina Oriana Aragona, Egidio Imbalzano, Federica Mamone, Valentina Cairo, Alberto Lo Gullo, Angela D’Ascola, Maria Adriana Sardo, Michele Scuruchi, Giorgio Basile, Antonino Saitta, and Giuseppe Mandraffino. Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease, Stem Cells International Volume 2016 (2016), Article ID 8043792, 12 pages; DOI: 10.1155/2016/8043792.
    42.       Egidio Imbalzano, Giuseppe Mandraffino, Marco Casciaro, Sebastiano Quartuccio, Antonino Saitta, Sebastiano Gangemi. Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review. Heart Fail Rev. DOI: 10.1007/s10741-016-9529-8.
    43.       Lo Gullo A, Aragona CO, Ardesia M, Versace AG, Cascio A, Saitta A, Mandraffino G. A Strongyloides stercoralis infection presenting as arthritis of sternoclavicular joint. Mod Rheumatol. 2016 Nov;26(6):981-983. doi:10.3109/14397595.2015.1132954. Epub 2016 Feb 16. PubMed PMID: 26709048.
    44.       Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, Morabito N, Lasco A, Gangemi S, Basile G. Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity. Arch Immunol Ther Exp (Warsz). 2015 Dec 12. [Epub ahead of print] PubMed PMID: 26658771.
    45.       Lo Gullo A, Mandraffino G, Bagnato G, Aragona CO, Imbalzano E, D'Ascola A, Rotondo F, Cinquegrani A, Mormina E, Saitta C, Versace AG, Sardo MA, Lo Gullo R, Loddo S, Saitta A. Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number. PLoS One. 2015 Aug 4;10(8):e0134602. doi: 10.1371/journal.pone.0134602. eCollection 2015. PubMed PMID: 26241902; PubMed Central PMCID: PMC4524708.
    46.      Imbalzano E, Vatrano M, Mandraffino G, Ghiadoni L, Gangemi S, Bruno RM, Ciconte VA, Paunovic N, Costantino R, Mormina EM, Ceravolo R, Saitta A, Dattilo G. Arterial stiffness as a predictor of recovery of left ventricular systolic function after acute myocardial infarction treated with primary percutaneous coronary intervention. Int J Cardiovasc Imaging. 2015 Dec;31(8):1545-51. doi: 10.1007/s10554-015-0733-8. Epub 2015 Aug 4. PubMed PMID: 26239135.
    47.       Basile G, Catalano A, Mandraffino G, Crucitti A, Ciancio G, Morabito N, Lasco A. Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values. J Am Geriatr Soc. 2015 Jun;63(6):1260-1. doi: 10.1111/jgs.13495. PubMed PMID: 26096407.
    48.      Vatrano M, Dattilo G, Mandraffino G, Gangemi S, Ciconte VA, Quartuccio S, Ceravolo R, Imbalzano E. A quick bailout ongoing of cardiogenic shock and iatrogenic dissection of the left main coronary artery. Int J Cardiol. 2015 Apr 1;184:473-4. doi: 10.1016/j.ijcard.2015.03.001. Epub 2015 Mar 3. PubMed PMID: 25756567. 
    49.       Mandraffino G, Imbalzano E, Mamone F, Aragona CO, Lo Gullo A, D'Ascola A, Alibrandi A, Cinquegrani A, Mormina E, Versace A, Basile G, Sardo MA, Cinquegrani M, Carerj S, Saitta A. Biglycan expression in current cigarette smokers: a possible link between active smoking and atherogenesis. Atherosclerosis. 2014 Dec;237(2):471-9. doi: 10.1016/j.atherosclerosis.2014.10.024. Epub 2014 Oct 18. PubMed PMID: 25463076.
    50.      Lo Gullo A, Mandraffino G, Imbalzano E, Mamone F, Aragona CO, D'Ascola A, Loddo S, Cinquegrani A, Alibrandi A, Mormina E, Bagnato G, Lo Gullo R, Sardo MA, Saitta A. Toll-like receptor 3 and interleukin 1β expression in CD34+ cells from patients with rheumatoid arthritis: association with inflammation and vascular involvement. Clin Exp Rheumatol. 2014 Nov-Dec;32(6):922-9. Epub 2014 Nov 7. PubMed PMID: 25436985.
    51.Imbalzano E, Scarpelli M, Mandraffino G, Creazzo M, Lizio G, Trapani G, Dattilo G, Dalbeni A, Tomasello C, Sardo MA, Saitta A. Combination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria. J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):956-64. doi: 10.1177/1470320314530018. Epub 2014 Jul 27. PubMed PMID: 25070350.
    52.  Imbalzano E, Mandraffino G, Ceravolo R, Di Stefano R, Saitta A. Renal denervation rapidly restores circulating proangiogenic hematopoietic cells in patients affected by drug-resistant hypertension. Int J Cardiol. 2014 May 15;173(3):591-2. doi: 10.1016/j.ijcard.2014.03.100. Epub 2014 Mar 21. PubMed PMID: 24698255.
    53.  Imbalzano E, Casale M, D'Angelo M, Mandraffino G, Giugno V, Di Bella G, Carerj S, Dattilo G. Cardiovascular risk and psoriasis: a role in clinical cardiology? Angiology. 2015 Feb;66(2):101-3. doi: 10.1177/0003319714527339. Epub 2014 Mar 25. Review. PubMed PMID: 24671131.
    54.  Mandraffino G, Imbalzano E, Sardo MA, D'Ascola A, Mamone F, Lo Gullo A, Alibrandi A, Loddo S, Mormina E, David A, Saitta A. Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement. J Hum Hypertens. 2014 Sep;28(9):543-50. doi: 10.1038/jhh.2014.7. Epub 2014 Feb 20. PubMed PMID: 24553637.
    55.  Mandraffino G, Dalbeni A, Paunovic N, Mormina EM, Imbalzano E. Radiation-induced heart and vessel atherosclerosis disease. Int J Cardiol. 2014 Mar 15;172(2):505-6. doi: 10.1016/j.ijcard.2014.01.059. Epub 2014 Jan 23. PubMed PMID: 24485624.
    56.  Imbalzano E, Saitta A, Lamari A, Trapani G, Lizio G, Creazzo M, Mandraffino G, Scarano M, Dattilo G. [Echo-Doppler evaluation of recent onset chronic venous insufficiency in elderly patients: does the heart have a role?]. Recenti Prog Med. 2013 Nov;104(11):569-73. doi: 10.1701/1370.15226. Italian. PubMed PMID: 24336618.
    57.  Lo Gullo A, Mandraffino G, Sardo MA, D'Ascola A, Mamone F, Loddo S, Alibrandi A, Imbalzano E, Mandraffino R, Mormina E, Saitta C, Lo Gullo R, David A, Saitta A. Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. Scand J Rheumatol. 2014;43(3):184-93. doi: 10.3109/03009742.2013.836564. Epub 2013 Dec 9. PubMed PMID: 24313545.
    58. Imbalzano E, Creazzo M, Mandraffino G, Sardo MA, Saitta A. Treatment failure of low molecular weight heparin in post-surgery orthopedic case. Int J Cardiol. 2013 Nov 5;169(3):e36-7. doi: 10.1016/j.ijcard.2013.08.109. Epub 2013 Sep 8. PubMed PMID: 24063927.
    59.  Mandraffino G, Sardo MA, Riggio S, D'Ascola A, Alibrandi A, Saitta C, Versace A, Castaldo M, Mormina E, Imbalzano E, Cinquegrani M, Bonaiuto M, David A, Saitta A. Circulating progenitor cells and the elderly: a seven-year observational study. Exp Gerontol. 2012 May;47(5):394-400. doi: 10.1016/j.exger.2012.03.007. Epub 2012 Mar 17. PubMed PMID: 22449458.
    60. Imbalzano E, Zito C, Carerj S, Oreto G, Mandraffino G, Cusmà-Piccione M, Di Bella G, Saitta C, Saitta A. Left ventricular function in hypertension: new insight by speckle tracking echocardiography. Echocardiography. 2011 Jul;28(6):649-57. doi: 10.1111/j.1540-8175.2011.01410.x. Epub 2011 Jun 15. PubMed PMID: 21676016.
    61.  Mandraffino G, Sardo MA, Riggio S, Loddo S, Imbalzano E, Alibrandi A, Saitta C, Cinquegrani M, Mormina EM, Saitta A. Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. Hypertens Res. 2011 Jul;34(7):876-83. doi: 10.1038/hr.2011.56. Epub 2011 May 19. PubMed PMID: 21593737.
    62. Cascio A, Mandraffino G, Cinquegrani M, Delfino D, Mandraffino R, Romeo O, Criseo G, Saitta A. Actinomadura pelletieri mycetoma--an atypical case with spine and abdominal wall involvement. J Med Microbiol. 2011 May;60(Pt 5):673-6. doi: 10.1099/jmm.0.027862-0. Epub 2011 Jan 20. Review. PubMed PMID: 21252272.
    63. Mandraffino G, Sardo MA, Riggio S, D'Ascola A, Loddo S, Alibrandi A, Saitta C, Imbalzano E, Mandraffino R, Venza M, Mormina EM, David A, Saitta A. Smoke exposure and circulating progenitor cells: evidence for modulation of antioxidant enzymes and cell count. Clin Biochem. 2010 Dec;43(18):1436-42. doi: 10.1016/j.clinbiochem.2010.09.023. Epub 2010 Sep 29. PubMed PMID: 20888331.
    64. Riggio S, Mamone F, Mandraffino G, Maimone S, Alibrandi A, Manti L, Saitta C, Tripodi PF, Sardo MA, Squadrito G, Saitta A. Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. Eur J Clin Invest. 2010 Aug;40(8):722-8. doi: 10.1111/j.1365-2362.2010.02323.x. Epub 2010 Jun 14. PubMed PMID: 20561029.
    65.  Sardo MA, Mandraffino G, Riggio S, D'Ascola A, Alibrandi A, Saitta C, Imbalzano E, Castaldo M, Cinquegrani M, Saitta A. Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients. Clin Exp Pharmacol Physiol. 2010 Sep;37(9):933-8. doi: 10.1111/j.1440-1681.2010.05407.x. Epub 2010 May 24. PubMed PMID: 20497421.
    66. Riggio S, Mandraffino G, Sardo MA, Iudicello R, Camarda N, Imbalzano E, Alibrandi A, Saitta C, Carerj S, Arrigo T, Saitta A. Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest. 2010 Mar;40(3):250-7. doi: 10.1111/j.1365-2362.2010.02260.x. PubMed PMID: 20415700.
    67.  Sardo MA, Mandraffino G, Campo S, Saitta C, Bitto A, Alibrandi A, Riggio S, Imbalzano E, Saitta A. Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. Clin Chim Acta. 2009 Aug;406(1-2):89-93. doi: 10.1016/j.cca.2009.05.024. Epub 2009 Jun 10. PubMed PMID: 19523462.
    68.   Sardo MA, Campo S, Mandraffino G, Saitta C, Bonaiuto A, Castaldo M, Cinquegrani M, Pizzimenti G, Saitta A. Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. Clin Chem. 2008 May;54(5):814-23. doi: 10.1373/clinchem.2007.095547. Epub 2008 Mar 13. PubMed PMID: 18339698.
    Aknowledgments  
    Awarded oral Communication  27th (European) Meeting on Hypertension and Cardiovascular Protection Milan (Italy), June 16-19, 2017 (ESH): Efficacy of monoclonal antibodies anti-proprotein convertase subtilisin-kexin type 9 in improving lipid profile and arterial stiffness in patients affected by familial hypercholesterolemia; Oral Communication
       
    Accommodation Grant Prize 26th (European) Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13, 2016 (ESH): “Circulating progenitor cells in hypertension: effectiveness of a treatment with olmesartan in improving cell number and miRs profile besides expected pharmacological effects”
    Presenting author
       
    Award for Best Poster Session 
    “Alberto Ferrari Poster Prize”
    26th (European) Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13, 2016 (ESH): “Circulating progenitor cells in hypertension: effectiveness of a treatment with olmesartan in improving cell number and miRs profile besides expected pharmacological effects”
    Presenting author
       
    Best original contribution Spring Meeting SISA/SIIA, Rimini, 11-12 March, 2016; section: Poster
    Contribution: AT1R blockade by Losartan as well as smoking cessation reduce Biglycan expression in uncomplicated subjects
    Presenting author
       
    Travel Grant Prize EAS European Congress, Innsbruck, May 29- June 1 2016; section: Poster
    Three original contributions
    Presenting author
       
    Travel Grant Prize EAS European Congress, Innsbruck, May 29- June 1 2016; section: Poster
    Three original contributions
    Co-author
       
    Young Researcher Prizes
    (SISA Travel Grant)
    Edizioni Congresso Nazionale SISA: 2006; 2007; 2009; 2010; 2011; 2012; 2013; 2014; 2015; 2016; 2017; 2018; 2019.
    Quattro volte premiato come presenting first author
    Sei volte premiato come non-presenting first author (co-primo)
    Dieci volte premiato come study coordinator author
    Nove volte premiato come non-presenting author
       
    Last Update: 
    May, 20th, 2021
     
     
    Including: autorizzazione al trattamento dei dati personali e la dichiarazione di veridicità dei dati secondo il D.P.R. n.445/2000.
     
     

I dati visualizzati nella sezione sono recuperati dalla Procedura Gestione Carriere e Stipendi del Personale (CSA), dalla Procedura Gestione Studenti (ESSE3), da Iris e dal Sito Docenti MIUR.

Argomenti Correlati

  • Segui Unime su:
  • istagram32x32.jpg
  • facebook
  • youtube
  • twitter
  • UnimeMobile
  • tutti